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Abstract
The pharmaceutical industry is currently shifting from batch to continuous manufacturing,
and for downstream processes, this shift can reduce costs and improve quality provided the
new unit operations are chosen properly. Electrospinning, a method of making nanofiber
mats from solutions of an active pharmaceutical ingredient (API), polymer and solvent, has
shown great promise for producing final solid dosage forms with minimal process steps. In
this thesis, we explore the use of electrospinning to produce fiber mats containing either
amorphous or crystalline API, aiming to develop the process such that it can be used for a
wide variety of final drug products. Key to utilizing electrospinning to make these products
is understanding the composition and behavior of the final fiber mats. For fibers containing
amorphous API, this means it is essential to understand the level of mixing between API
and polymer and the stability of the final product, and for fibers containing crystalline API,
the crystal morphology and extent of dispersion within the polymer must be understood.
The mixing level of amorphous API and polymer in fibers was analyzed using solid state
nuclear magnetic resonance relaxation times. It was found that, for aliskiren/poly(vinyl
pyrrolidone) and indomethacin/poly(vinyl pyrrolidone) formulations, the materials are inti-
mately mixed following electrospinning, with no phase separation down to a 2-10 nm domain
size. This was not the case for a 4:1 aliskiren:poly(vinyl pyrrolidone) formulation prepared
by hot melt extrusion, an alternative method for co-processing API and excipients, as solid
state NMR analysis showed phase separation with domains of 20-80 nm or larger. The
same electrospun formulations were shown to be stable as solid solutions for 6 mo. when
stored at 40*C in a desiccator, indicating that electrospinning is a viable method to produce
physically stable formulations containing amorphous API.
To produce fibers containing crystalline API, two methods were used. In the first,
an API/polymer solution was electrospun using the same method as for producing fibers
containing amorphous API. It was found that spinning with a crystalline polymer can
result in crystalline API in the fibers, but the crystallinity ultimately depends on more
than the polymer and API properties. Due to the complexity of using this method, we
developed the second method, involving electrospinning a suspension of API crystals in the
polymer/solvent solution. We demonstrated the feasibility of spinning particles of up to
10 pm diameter using polystyrene beads and then applied the process to electrospin two
different APIs, albendazole and famotidine. The electrospun mats contained crystalline
APIs well-dispersed within the fibers and tablets prepared from the mats displayed a higher
dissolution rate than fibers prepared from powder blends.
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Chapter 1
Introduction
The process of going from raw ingredients to a formulated drug product is long,
complicated and expensive. In current pharmaceutical manufacturing practices, the
operations are done batch-wise, an often inefficient method of production. One area
that is particularly costly is the lengthy route from purified active pharmaceutical
ingredient (API) to final product, as this section often includes time-consuming dry-
ing, blending and granulation steps. In developing new continuous manufacturing
processes, one approach is to co-process the API and all necessary excipients from a
solution to a tablet without any powder handling steps.
Various continuous processes have been proposed to decrease the powder handling
steps and provide efficient blending of API and excipients including melt extrusion [1,
2], thin film casting [3] and electrospinning [4-8]. Though a less-traditional technique,
electrospinning has distinct advantages over extrusion and thin film casting. Because
of the high surface area generated during electrospinning, the evaporation rate of the
solvent is incredibly high, allowing for more efficient drying at ambient temperatures
than is possible with thin film casting. In addition, no heat is necessary to blend
ingredients during electrospinning, as they are already well blended in the liquid
solution prior to spinning, making it more applicable for heat-sensitive API than
melt extrusion.
In electrospinning, fibers of 20-2000 nm diameter are produced from a solution
of a polymer, solvent and any desired additives. This approach, however, has a very
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low production rate, on the order of 1 mg solids/min for the materials used in this
work. This is insufficient for application to an industrial manufacturing process, and
so we use a newer technology for the scale up of electrospinning, referred to as "free
surface electrospinning" or "needleless electrospinning." In free surface electrospinning,
jetting occurs from a free liquid surface, such as a film on a rotating drum, disk or wire
spindle or from the surface of gaseous bubbles [9-18]. This results in the formation of
multiple Taylor cones and jets and a high production rate, on the order of 8 mg/min
for the materials and equipment used in this work. The free surface electrospinning
technique has previously be adapted as a commercial unit and is available through
Elmarco (Liberec, Czech Republic).
Though scale-up of electrospinning is possible with such approaches as free sur-
face electrospinning, a further challenge prevents the technique from being applied
for pharmaceutical manufacturing. Due to the rapid solvent evaporation during
electrospinning, the drug is often present in the resulting fibers in its amorphous
form [6-8, 19, 20]. This can be advantageous for a poorly water soluble drug, as
the amorphous form often has a higher water solubility than the crystalline form,
but it also introduces physical stability issues, with the amorphous API crystallizing
over time [21]. For this technique to become generally applicable as a manufacturing
process, it must also be able to produce fibers containing crystalline API.
My thesis approaches this challenge in two ways. First, I acknowledge that the
amorphous form is potentially useful and aim to develop a better understanding of
the molecular behavior of the amorphous drug and polymer mixture. Second, I design
and characterize a process for producing crystalline drug in the electrospun fibers, a
technique that will allow electrospinning to be used for a much larger fraction of APIs.
These are both necessary problems to overcome in order to apply electrospinning to
large-scale pharmaceutical applications.
Obtaining API in the amorphous form using electrospinning is an exciting result
for researchers studying poorly water soluble drugs, as the combination of high surface
area of the fibers and amorphous API aids in increasing solubility. One factor that
strongly affects the rate of solid state crystallization, and thus the stability of the
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amorphous form is the mobility of the API. Many studies have been done on methods
to decrease the mobility of the API by co-processing with polymer excipients, and
electrospinning of drug and polymer is one of the leading methods of doing this. Two
mechanisms may contribute to the decreased mobility: the antiplasticizing effect of
polymer excipients [22,23] and hydrogen bonding between some API and excipients
[23-25]. These effects are strongest in a solid solution, where the contact between the
drug and the polymer is maximum.
Some have argued that, following electrospinning, the API is present in the poly-
mer as a solid solution, basing their conclusion on the burst release dissolution pro-
file [20]. The dissolution profile, however, would be similar for a solid solution and
a solid dispersion with a small domain size. Another method commonly used in the
literature to support the claim of a solid solution is by measuring the glass transition
temperature (Tg) of the mixture. According to the Gordon-Taylor equation, for a sys-
tem with no intermolecular interactions, there will be only one Tg of a homogeneous
mixture and it will be an intermediate of the two components [26]. Verreck et al.
measured the glass transition temperature of electrospun fibers containing itracona-
zole and PVP and found that there was only one Tg for the mixture, but it was not
where predicted by the Gordon-Taylor equation, indicating either phase separation or
a solid solution with interaction between components [8]. The Tg, however, has been
shown to be a poor indicator of phase separation in many cases [27-30]. Thus, despite
the potential electrospinning has shown for producing amorphous formulations, it is
still necessary to find conclusive evidence that the end result is a solid solution prior
to utilizing this technology to create final solid dosage forms.
For dispersions of amorphous materials, there are few options to quantify domain
size of any phase separation when the domain size is likely 2-50 nm. Solid state nuclear
magnetic resonance (NMR) has been used to characterize the domain size of solid
dispersions containing two amorphous materials [31-35]. The spin lattice relaxation
time and the spin lattice relaxation time in the rotating frame (T1 (H) and T1 ,(1 H),
respectively) are measurable time constants for proton spin diffusion and are related
to the diffusion length scale [35]. If the relaxation time measured from the NMR
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peaks of one component in a mixture is equal to that measured from the NMR peaks
of the other component in a mixture, the sample is intimately mixed on that length
scale. If the relaxation time values differ, then the sample has heterogeneities of that
length scale or larger.
In this work, solid state NMR is used to measure the spin lattice relaxation times
for formulations prepared by electrospinning in order to determine whether the APIs
and polymer were well-mixed down to small length scales (Section 4.2.3). As support-
ing evidence, the Tg of the mixture was determined and compared to that predicted
by the Gordon-Taylor equation (Section 4.2.2). To compare electrospinning to other
methods of forming solid dispersions, an API and polymer mixture was prepared using
hot melt extrusion and also tested using solid state NMR relaxation time analysis.
This study also utilizes the solid state NMR relaxation time analysis to examine
the physical stability of amorphous API in electrospun solid solutions (Section 4.3.4).
Typical physical stability studies of pharmaceutical formulations involve storage at
high temperatures and/or high humidity and analysis via X-ray diffraction (XRD)
and differential scanning calorimetry (DSC) to determine crystallinity as a function
of time [36]. Here, we apply solid state NMR relaxation time analysis to investigate
the homogeneity of solid solutions over time, rather than only examining the crystal-
lization of the API over time. Since physical stability is enhanced in a solid solution,
it is desirable that the two components remain intimately mixed over a typical shelf
life, preventing an opportunity for crystallization. We also use Fourier transform in-
frared spectroscopy (FTIR) to probe the interactions between the API and polymer
to determine whether interactions contribute to stability (Section 4.3.3).
Even if eletrospinning produces stable amorphous solid solutions, there will be
API for which a crystalline form will be preferred. Hence, we focus on electrospinning
formulations containing crystalline API in the second half of the thesis (Chapter 5).
We explore two approaches to forming fibers containing crystalline API:
1) Electrospin a solution of fully dissolved API/polymer/solvent with parameters
chosen such that the API is crystalline following electrospinning.
2) Electrospin a suspension of API crystals in a dissolved polymer solution, with
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the solvent chosen such that the API crystals will not dissolve.
A few studies on electrospinning of API have found that the API is partially crys-
talline immediately after electrospinning using approach (1) [37-39]. All three studies
used a polymer that itself crystallizes during electrospinning, either polycaprolactone
(PCL) or poly(ethylene oxide) (PEO). Natu et al. found that the API was par-
tially crystalline in only one formulation examined, that with greater than 10 wt%
API [38], and Ignatious et al. determined that, at drug loadings higher than 35.9
wt%, nabumetone exhibits a melting endotherm when analyzed immediately after
electrospinning [39]. Section 5.2 presents the results of electrospinning two APIs dis-
solved in solutions with 9 different polymers. The percent crystallinity and the fiber
morphology are analyzed to determine which API or polymer properties, if any, de-
termine whether the API crystallizes during the electrospinning process. Though the
three previous studies obtained fibers containing crystalline API by this method, the
studies considered only one API/polymer combination each and did not go in depth
as to how the API is able to crystallize despite the high evaporation rate.
As an alternative to crystallization during spinning, we present a method of elec-
trospinning suspensions of API crystals in a polymer solution. Examples of particles
that have been electrospun along with the polymer are various types of nanoparticles
(2-100 nm), including magnetite [40] and TiO2 [41,42] with diameters of less than
20 nm, CaCO 3 with diameters of 40-100 nm [43,44], carbon black nanoparticles with
diameters of 10-20 nm [45], and metals such as iron and nickel with diameters of 1-20
nm [46, 47]. One active research area is electrospinning of carbon nanotubes, which
have small diameters but often have a very high aspect ratio [41,48,49].
A few researchers have employed even larger particle sizes, including Salalha et
al., who electrospun solutions containing bacteria and viruses, some on the order of
1 tm x 2 pm, [50] and Wang et al. who electrospun solutions containing clays as
large as 4-5 pm in lateral dimensions [51,52]. Two groups have electrospun solutions
containing silica or polystyrene beads with the aim of producing superhydrophobic
surfaces, succeeding in spinning with particles up to a 1 pm diameter [53,54]. None of
these papers have addressed the effect of particles, particularly large (micro) particles,
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Upstream Final API Mixing with Free surface
Processes crystallization polymer and electro-
sonication spinning
Figure 1-1: Proposed manufacturing process for electrospinning API crystal suspen-
sions to produce fibers containing crystalline API.
on fiber diameter. In addition, all of this work has been done using the single needle
electrospinning apparatus, which has a low production rate.
Section 5.3 presents a study of the spinnability of microparticles using free surface
electrospinning. Spherical polystyrene beads of 1, 3, 5, and 10 pm diameter were used
as model particles in order to determine how particle size affects the spinnability with
the free surface approach and the final fiber diameter.
Electrospinning of particles was also applied to API crystals and the results are
presented in Section 5.4. For this approach we envision a process such as the one
in Figure 1-1. The electrospinning would follow the final API crystallization step,
without the need to re-dissolve the API or dry the crystals, and the only added step,
mixing with a polymer and sonication, is a simple and quick process.
Once we have demonstrated that producing fiber mats containing crystalline API
is feasible, we look deeper into the properties of the resulting mats, particularly the
properties affecting bioavailability. The dissolution rate (related to the bioavailabil-
ity) is effected by the crystal size, the extent of dispersion in the polymer, and the
crystalline morphology. It is important to understand these properties and how they
compare to the API crystals as received and/or blended mixtures with the same excip-
ient. Though an improved dissolution rate compared to a compressed powder tablet
is not the aim in this case, an understanding of any differences in the dissolution rate
is essential.
The overall aim of the work in this thesis is to carefully characterize the fibers
resulting from electrospinning API and excipients such that we develop sufficient pro-
cess understanding to apply electrospinning to a continuous industrial pharmaceutical
manufacturing line. Specific aims include:
1) Characterize the mixing level of the amorphous API and polymer immediately
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following electrospinning.
2) Determine the mixing level of the amorphous API and polymer and crystallinity
of the API as a function of time over a 6 mo. period.
3) Determine the spinnability of particles of similar size to API crystals and the
effects of the particles on the morphology and diameter of the final fibers.
4) Develop a method for producing fibers containing crystalline API and charac-
terize the crystal size, extent of dispersion in the polymer, and crystalline morphology
of the API in the resulting fiber mat.
31
32
Chapter 2
Background
2.1 Continuous Pharmaceutical Manufacturing
A primary driving force for the work in this thesis comes from a shifting manu-
facturing landscape for pharmaceutical products. Traditionally, all pharmaceutical
manufacturing has been done batch-wise, where operations are carried out in discrete
intervals and the materials are transferred as a batch from one step to the next, as
with baking, where the ingredients are mixed in one dish and then transferred to
another for baking in the oven. An alternative to this, and one that is used often
in both large-scale chemical production and food processing, is continuous manufac-
turing, where the material moves through the entire process without interruption.
The pharmaceutical and fine chemical industries have been slow to adopt continuous
manufacturing. As of 2008, the top 300 organic chemicals were made continuously,
but 90% of the next 2700 were made batch-wise, and for numbers 3000-30,000, 97%
were made batch-wise [55].
To understand this trend and the recent shift in the pharmaceutical industry
towards continuous manufacturing, one must understand the differences, particularly
those that affect cost and profit, between the two approaches to manufacturing a
chemical product. Batch processing is often associated with greater flexibility, as
it is based on stirred tank reactors that can be used for many different products
and processes, whereas for continuous manufacturing the equipment is more variable
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and is designed around the chemistry of each product [55]. What follows from this
is that one must have a better process understanding in order to run a continuous
manufacturing plant well enough to compensate for the flexibility provided by the
batch processes. This is both due to a need to design equipment properly as well as a
need to be able to quickly fix a problem in the line before large amounts of product are
ruined; for continuous manufacturing, a batch cannot be thrown out and a new one
started [55]. This can be particularly challenging for pharmaceutical manufacturers
who rely on high quality in the production line and have little time to develop process
understanding for each product due to the pressure to bring a product to market. The
United States Food and Drug Administration (FDA) has recently recognized this,
and as of 2005 began an initiative encouraging process analytical technology (PAT),
aiming to increase in-line analysis of product quality and increase the understanding
of the behavior of the operations [56].
Continuous manufacturing in general can have many advantages over batch. Equip-
ment utilization tends to be higher, as particular operations do not shut down and
restart after discrete intervals as they do in batch manufacturing. The equipment also
tends to be smaller; many of the first manufacturing processes being implemented
continuously in the pharmaceutical industry are based on microreactor designs [55].
This can be advantageous for capital costs associated with building and operating a
chemical plant.
For many continuous manufacturing operations, the scale-up from a lab scale
to a production scale is relatively simple compared to that for batch operations.
For the chemical reaction steps of API production, when microreactors are used for
the operation, they can be scaled up by running multiple units in parallel [56]. For
electrospinning, the scale-up is similar, by the use of additional electrode length, either
by increasing the length within a single piece of equipment or by adding multiple units
in parallel.
One of the key traits of continuous manufacturing is that the processes often have
better mixing, and thus better heat and mass transfer. This allows each molecule
to experience a similar environment, contrary to problems with dead spots in vessel-
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Figure 2-1: A. Traditional downstream manufacturing process, B. Proposed continu-
ous downstream manufacturing process with electrospinning
type reactors and crystallizers, and increases quality as well as yield of the final
product. For downstream manufacturing, mixing is a great concern, as the materials
are generally in the solid form where it is much more difficult to achieve uniform
mixing. A typical downstream process consists of crystallization, drying, milling,
granulation, blending and tabletting steps (Figure 2-1-A). In developing continuous
processes, we aim to remove many of these time-consuming correction steps. For the
electroprocessing work, we envision a manufacturing line more like that in Figure
2-1-B. This would allow us to remove many solid handling steps and improve mixing
of API and excipients, but most importantly it would replace downstream batch
processes with a new continuous manufacturing process.
2.2 Electrospinning
Electrospinning refers to the process of using electrostatic forces to produce fibers from
a polymer solution. First patented as a "Method of Dispersing Fluids" by William
Morton [57], electrospinning has only recently begun to be applied to manufacturing
products such as membranes and coatings and be explored for applications in tissue
engineering and pharmaceuticals.
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Various configurations may be used for electrospinning, which we will discuss later,
but for a majority, the process begins with a charged droplet some distance away from
a grounded electrode. At sufficient applied potential, the charge repulsion forces at
the surface of the drop become great enough to overcome the surface tension forces
and deform the droplet into a Taylor cone. At slightly higher applied fields, a jet is
emitted from the apex of the cone, sending a fiber towards the grounded plate [58].
During the initial period, just after the jet is emitted from the cone, the fluid
accelerates towards the grounded plate due to the influence of the electric field [59].
Little solvent evaporation occurs during this time [60]. At a point between the apex
of the cone and arrival at the grounded plate, the charge repulsion in the jet leads to
instabilities. Multiple types of instabilities are possible, but the so-called "whipping
instability" is the most common for electrospinning [59]. The whipping instability
was treated rigorously by Hohman et al. [61, 62]. During the whipping portion of
electrospinning, the jet thins rapidly and significant solvent evaporation occurs [59].
As the jet diameter decreases, the effects of the acceleration of the jet in the electric
field and the bending of the electric field lines become insignificant, and at small jet
diameters, the charge repulsion forces decrease until they exactly balance the surface
tension. This point signals the end of thinning and the diameter at this point is the
terminal jet diameter [63]. However, various conditions, including solvent evaporation
effects and elastic forces may cause the final fiber diameter to be larger than the
predicted terminal jet diameter. If applicable, the jet then travels the remaining
distance to the grounded plate and is collected as a non-woven mat.
The typical electrospinning set-up is referred to as "single-needle electrospinning",
and it is illustrated in Figure 2-2. It consists of a container for the spinning solution,
in our case a syringe attached to a pump, and a needle through which the fluid
is pumped and at the end of which a droplet forms. A high voltage power supply
provides charge to the solution and a grounded surface, often a flat metal plate, serves
as the collection plate.
Alternative designs have been used, particularly ones whose aim is to increase
the production rate of the electrospun fibers. The scale-up designs typically fall into
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Figure 2-2: Single needle electrospinning apparatus consisting of a syringe and needle,
a high voltage power supply and a grounded electrode
two categories: multi-needle or free surface (needleless) electrospinning. Multi-needle
approaches aim to utilize a similar set-up to single-needle electrospinning, but with an
array of needles. A key concern with this method, however, is the interaction between
the electrospinning jets. Careful design of the configuration of needles and control of
the electrospinning parameters is necessary to obtain spinning from all needles and a
desired distribution of collected fibers [64-66].
Free surface approaches, on the other hand, rely on the self-organization of droplets
on a thin liquid surface. This surface can take the form of a gaseous bubble [18] or
a film on a rotating drum, disk, or wire electrode [9-17]. An illustration of a free
surface electrospinning apparatus with a wire electrode is shown in Figure 2-3. During
operation, the wire spindle rotates and the wire electrodes move through the liquid
bath, entraining a layer of fluid on the wire as it passes the air/fluid interface. Due to
Plateau-Rayleigh instabilities the fluid layer breaks into droplets, and, when sufficient
electric field is applied, these droplets jet and electrospin until either the critical
electric field condition is no longer met or the droplet volume is depleted (Figure
2-4). This process through fluid entrainment and jetting is discussed extensively in
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Figure 2-3: Free surface electrospinning apparatus consisting of a charged liquid bath,
a grounded collection plate, and a wire spindle type of electrode.
Forward and Rutledge, 2012 [17].
2.3 Pharmaceutical Formulation Development
Though developing an effective active pharmaceutical ingredient (API) is an impor-
tant part of designing a new pharmaceutical, developing an appropriate final drug
product, complete with excipients, is also essential. The release rate of an API in the
Figure 2-4: Free surface electrospinning off of a wire electrode. A. Conical droplet on
the wire in the presence of an electric field at time t = 0 ms. B. Extended conical
droplet at time t = 33 ms.
droplet at time t = 99 ms.
C. Jetting droplet at time t = 66 ms. D. Depletion of
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body, as well as its solubility can depend on the API particle size, the interactions
between the API and excipients, the crystallinity of the API, the dispersability of the
solid dosage form, etc. These considerations can cause considerable difficulty in devel-
oping a new drug product, and work in this area is called pharmaceutical formulation
development.
In this work, we have chosen a particular blending and drying method, electro-
spinning, and we explore ways to make it applicable to a wide variety of formulation
needs. Most importantly, we aim to make it applicable to forming both amorphous
and crystalline solid dispersions.
2.3.1 Amorphous Pharmaceutical Formulations
The amorphous form of an API, also referred to as a glass, is one in which there is no
long range order, contrary to crystalline forms, where each polymorph has a unique,
repeating configuration of molecules. Much research has been done on preparing
and understanding the amorphous form for pharmaceuticals, driven primarily by one
property of amorphous materials: the free energy of the amorphous state is higher
than that of the crystalline state, and thus the solubility of an amorphous material is
higher than that of its crystalline counterparts [67]. In 1995, Amidon and co-workers
developed a method of classifying API based on their solubility and permeability to
be able to predict how well in vitro dissolution studies would correlate with in vivo
behavior of the drug, and this is called the biopharmaceutical classification system
(BCS) [68]. API fall into one of 4 classes: I. high solubility, high permeability, II.
low solubility, high permeability, III. high solubility, low permeability, and IV. low
solubility, low permeability. It is the class II and IV APIs that are the target of much
of the research on formulating API in the amorphous form.
Utilizing the amorphous form for drug products, however, is challenging. Ther-
modynamically, the crystalline form is more favorable, and this often leads to the
crystallization of the amorphous form over time, thereby a change in solubility over
time. In working with amorphous formulations, the stability of the amorphous form is
more broadly defined than merely the thermodynamic stability; it refers to how well
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the amorphous form resists crystallization, either by being more thermodynamically
stable or by being kinetically stable. Despite being thermodynamically unfavorable,
the amorphous form can be obtained for many compounds for one or both of the
following reasons [69]:
1) The amorphous form is nearly as thermodynamically stable as the crystalline
form, possibly due to poor molecular packing.
2) The time required to form a crystal is long, allowing one to use a preparation
method that traps the molecule in the amorphous form for a desired period of time.
For method (1), if the thermodynamic stability is similar to that of the crystalline
form, the API may not have significantly better water solubility than the crystalline
form and thus formulating it as an amorphous form would be unnecessary. However,
one may take advantage of method (2) for formulating many APIs in their amorphous
form. There are many processing methods that have been developed, including rapid
drying techniques such as lyophilization, spray drying, and electrospinning, and rapid
cooling techniques such as melt quenching with liquid nitrogen [69]. These methods
begin with the molecules in a liquid state where they are disordered and rapidly bring
them to a solid state without leaving time for the molecules to order themselves before
they are limited by low mobility [70].
Not only is it necessary to properly prepare the amorphous form, but it is es-
sential to stabilize it, i.e. keep it from crystallizing, for the desired shelf life. For
pharmaceutical products this may be on the order of 2-3 years. Often additional ex-
cipients are added to the amorphous API to further decrease its molecular mobility,
either by hydrogen bonding with the API or by being a physical barrier between API
molecules [22-25]. Formulations of this type, where one or more excipients are blended
to some degree with the API are called solid solutions or dispersions, depending on
the mixing level.
For crystalline systems, the distinction between a solid solution and solid dis-
persion is clear, as a crystal has a rigid structure and the dispersed molecules will
exist as distinct molecules in either interstitial spaces or as substitutes for the carrier
molecules. For amorphous materials on the other hand, the amorphous API molecules
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Figure 2-5: Illustration of a solid solution, where API and polymer are molecularly
mixed and a solid dispersion, where clusters of API exist within the polymer
within an amorphous polymer carrier will be disordered and will be irregularly dis-
persed throughout the carrier [71]. By the strictest definition, a mixture is called
a solid solution when there is molecular level mixing and a solid dispersion when
clusters of API molecules exist (illustrated for a drug and polymer in Figure 2-5) [71].
The strict definition is difficult to use, as there are no techniques that can identify
true molecular level mixing [71]. Table 2.1 lists some of the techniques used to analyze
solid solutions and dispersions and their limits. In this work, we use the solid state
NMR technique due to its low spacial limit, applicability to our samples, and our ease
of access to the equipment through the Francis Bitter Magnet Lab (FBML) at MIT.
Because of this, we define a solid dispersion as a mixture having phase separated
domains greater than 2-10 nm and a solid solution as being homogeneous down to a
length scale of 2-10 nm.
For stabilizing an amorphous API, it is most desirable to have a solid solution.
This will allow the maximum contact between the excipient and API for hydrogen
bonding as well as provide the best physical barrier to the API molecules forming
clusters and, subsequently, crystals.
2.3.2 Crystalline Pharmaceutical Formulations
Similar to considerations when developing amorphous pharmaceutical formulations,
one must choose materials and processing methods for crystalline formulations such
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Technique Spacial Limit (approx. Practical Limits
domain size measurable)
Scanning Electron Microscopy 50 nm No contrast between amorphous polymer and
amorphous API
Transmission Electron Microscopy < 1 nm [72] Different domains must have different electron
densities in order to contrast
X-ray Diffraction 1 pm Can only determine particle/domain size for crystals
Raman Mapping 2 pm [73] Difficult to focus for spot sizes < 2 pm
Fluorescence Resonance Energy Transfer 1-10 nm [74] Requires fluorescent materials,
measures only fraction of molecules present
as clusters, for low API concentrations
Solid State Nuclear Magnetic Resonance 2-10 nm Time consuming, specialty equipment
Atomic Force Microscopy with 100 nm [75] Difficult to mount electrospun materials for AFM,
Fourier Transfer Infrared Spectroscopy mainly a surface technique
Table 2.1: Methods of analyzing solid dispersions.
with available instruments.
Where cited, spacial limit is from literature, otherwise it is from experience
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that the final drug product has a desired bioavailability and is stable in the chosen
form over time. Primary factors affecting bioavailability (i.e. solubility in the body
and permeability of membranes) are the crystalline polymorph and crystal size.
Polymorphism is the ability of a molecule to exist in more than one crystal struc-
ture (long range ordered repeating arrangement of molecules). Like amorphous API,
some polymorphs have higher internal energy than others, and thus the solubility and
bioavailability of a drug product may be different depending on which polymorph is
present. It is essential in formulation development to be aware of the polymorphism
of the APIs and control the polymorph obtained such that the bioavailabilities of the
APIs are constant over time.
Crystalline particle size affects the dissolution rate of an API primarily through
the surface area available to dissolve, as predicted by the Noyes-Whitney equation:
dm DA
dt = h(Cat -C) (2.1)dt h
where d is the dissolution rate, D is the diffusion coefficient, A is the surface area
for diffusion, h is the diffusional path length, Cat is the solubility and C is the
concentration in solution [71]. Small particles have a larger surface area for a given
volume and thus will have a higher dissolution rate than large particles.
When formulating poorly water soluble APIs, there are many options for produc-
ing small particles to increase the dissolution rate including wet media milling [76],
sonication [77], antisolvent precipitation [78-81], and other rapid precipitation tech-
niques [82-86]. Often when these formulations are prepared, they are made using
polymer excipients or surfactants, forming some type of solid dispersion. This is done
for two reasons:
1) the polymers or surfactants are chosen such that they interact with the crystal
surface, hampering growth during precipitation [80-82,86]
2) the excipients separate the API particles in the solid form and keep them from
aggregating [84,87].
Careful consideration of the polymorphism and particle size distribution is essen-
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tial to properly formulate a drug product for the final oral dosage form. Thus, when
exploring the use of electrospinning for producing fibers containing crystalline API
(Chapter 5), we examine these properties in order to determine whether the method
is viable as a pharmaceutical manufacturing process.
2.4 Solid State Nuclear Magnetic Resonance
A large part of this thesis utilizes solid state NMR analysis techniques. In this section,
we will describe the basics of NMR, the application of NMR to studying solid samples,
and the specific techniques used in this work.
The use of NMR is based on the principle that a spinning charge generates a
magnetic field. Any nucleus that has an odd mass number or atomic number (i.e.
has an odd number of protons and neutrons or the sum of the number of protons and
neutrons is odd) has a spin and can be analyzed using NMR. Not all of these nuclei
have 1/2 spins; for example, sodium has a 3/2 spin, but is studied using NMR. In this
work, however, only the most commonly studied nuclei, 'H and "C, are discussed,
and they both have 1/2 spins. In the presence of an applied field, the spin for these
nuclei can exist either in the +1/2 or -1/2 state, where the +1/2 state is aligned with
the applied field and the -1/2 state is against the applied field.
Irradiation of a sample with radio frequency (rf) energy equal to the energy dif-
ference between the +1/2 and -1/2 state will cause the spins to jump to the higher
-1/2 state [88], and this is illustrated in Figure 2-6.
A key property of this phenomenon is that different atoms will make the jump at
different applied rf energy. Electrons of an atom and nearby atoms can generate an
additional magnetic field in the direction of the applied field. This causes the atom
to require more rf energy to jump to the higher energy state than an atom with no
interference from a chemical environment, and this difference is called the chemical
shift. This principle is what allows us to use NMR to study chemical structures [88].
Special considerations must be made, however, for NMR of solid state samples.
The chemical shift, derived from nuclear spin interactions, depends on the orientation
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Figure 2-6: Illustration of basic principles of NMR: A spinning charge generates a
magnetic field that can be aligned with (+1/2) or against (-1/2) an applied field.
When radio frequency (rf) energy is applied the spins jump to a higher energy state.
of the molecule, with the nuclear spin interactions being proportional to (3 cos 2 OR -1),
where 0 R is the angle at which the sample is inclined relative to the applied field. In
a liquid, the thermal motions of the molecules cause the influences of orientation on
the nuclear spin interactions to average to zero. In a solid, however, the molecules
are rigid and therefore all orientations are detected and the peaks are significantly
broadened. If 6 R is set to 54.740, then (3 cos 2 OR - 1) is equal to zero and the average
orientation dependance of the nuclear spin interactions is also zero. This is only
sufficient to remove the effects of orientation if the sample is not only inclined at OR,
but also spun at a high enough rate that the angle of the spin interaction relative to
the applied field is averaged rapidly compared to the orientation dependance of the
nuclear spin interaction [89]. This experimental set-up, spinning the sample rapidly
at an angle of 54.74 to the applied field is referred to as magic angle spinning (MAS)
and is used in nearly all solid state NMR studies.
Orientation effects are not the only challenge in using solid state NMR. The tech-
nique also suffers from poor signal to noise ratio, particularly when performing 13C
solid state NMR. In nature, 13 C is only present at a rate of 1.1%, whereas 'H is
present at a rate of 99.9% [89]. This leads to two problems:
1) collection of sufficient data on the 13C will take a very long time due to the
small number of atoms
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Figure 2-7: The pulse sequence for inversion recovery experiments (T1 ('H)) consisting
of an initial rf pulse, a delay for recovery, a second rf pulse, a cross polarization (CP)
pulse and two pulse phase modulation (TPPM) during detection of the free induction
decay (FID)
pulse
1H CP TPPM
13C OP Spin Lock FID
Figure 2-8: The pulse sequence for spin lock experiments (T1,( 1 H)) consisting of an
initial rf pulse, a cross polarization (CP) pulse, a spin lock period and two pulse phase
modulation (TPPM) during detection of the free induction decay (FID)
2) dipolar coupling between the far more abundant 1H and the 13C (referred to as
heteronuclear coupling) will broaden the signal significantly.
To remove the effects of dipolar coupling (2), a proton decoupling (PD) sequence is
used. There are many approaches to PD, most based on the same principle; applying
irradiation at a very high power at the frequency of the proton resonance. The
application of the irradiation at the frequency very close to the proton resonance
causes the 1H spins to repeatedly transition between +1/2 and -1/2. If the rate
of transitions is fast enough (i.e. a high enough rf power is used), the coupling will
average to zero [89]. Various methods can be used for PD, but in this work we use the
two pulse phase modulation (TPPM) pulse sequence [90], the most commonly used
pulse sequence at this time. The TPPM is generally applied during the detection
time only, as can be seen in Figures 2-7 and 2-8.
A technique known as cross polarization (CP) is used to increase the signal during
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13C NMR experiments. A special pulse sequence for the rf energy allows the 13C to
obtain magnetization from 1H spins, thereby increasing the 13C signal. Simply, the
approach is such that rf pulses are used to set the gaps between spin states of the
'H and 13 C equal to one another. The samples are held in that position for a given
contact time, allowing the transfer of magnetization, which can then be detected on
the 13C [89]. The incorporation of the CP pulse sequence can be seen in Figures 2-7
and 2-8.
These three techniques, MAS, TPPM, and CP are commonly used to obtain high
quality solid state NMR spectra.
For the work in this thesis we use a property that can be measured by solid state
NMR: spin diffusion. Like heat or mass, magnetization diffuses from areas of high
magnetization to areas of low magnetization, following Fick's law [91]:
m(r, t) = V [b(r)Vm(r, t)] (2.2)
where m is the magnetization, D is the diffusion coefficient, r is the space vector and t
is the diffusion time. This diffusion is not a physical movement, but rather a transfer
of magnetization between neighboring nuclei through homonuclear (same nucleus, i.e.
13 C and 13 C or 1H and 1H) couplings [92]. The diffusion is most efficient between
protons, and we can indirectly measure that using the CP pulse sequence. We do
not measure it from 'H spectra directly because the signals overlap significantly, so it
is much easier to use the 13C spectra, where the peaks are more separated from one
another [92].
When the sample is subjected to an rf pulse, we obtain a non-equilibrium distribu-
tion of spin states. It is a distribution because not all protons in the same sample are
in the same chemical environment, so they have different magnetizations [92]. It is the
relaxation from this distribution that we observe. By examining the magnetization
change for various mixing times (delay for the inversion recovery sequence, Figure
2-7, and spin lock for the spin lock pulse sequence, Figure 2-8), we can determine a
time constant for the diffusion, known as the spin lattice relaxation time (Ti(1 H)) for
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the inversion recovery sequence and the spin lattice relaxation time in the rotating
frame (Tip( 1H)) for the spin lock sequence.
The measured time constants are dependent on the chemical environment, and
thus dependent on the materials in the sample and the level of blending, if any. By
solving Equation 2.2, either analytically or by using estimates, we can obtain a domain
size for diffusion, L, corresponding to the time constant [92]. In this work we use a
simple solution [34]:
L = 6DT (2.3)
where D is the diffusion coefficient and T is the time constant, either T1 (1 H) or
T1,( 1 H). If the domain size of the phase separation of the API or polymer is smaller
than the diffusion length L, then all L-sized domains will have similar diffusion be-
havior and the value of the relaxation time will be the same whether determined
from one component or the other (in our case the API or polymer peaks). This is
illustrated in Figure 2-9-A, where the API (gray boxes) and polymer (white boxes)
phase separation has a small domain size. If the domain size of the phase separation
of the API or polymer is the same size or larger than the diffusion length L, then the
L-sized domains will show different diffusion behavior and two distinct values of the
time constant will be measured [91]. This is illustrated in Figure 2-9-B, where the
API and polymer phase separation has a large domain size [34,91,92]. The latter case
indicates phase separation of domain size L or larger and is referred to in this work
as a "solid dispersion." The former case indicates no phase separation of domain size
L or larger and is referred to in this work as a "solid solution."
This method of examining phase separation in mixtures was first applied to
polymer blends [34], but has since been used to study API/polymer solid disper-
sions [4, 31, 32, 93].
Solid state NMR is a powerful technique for examining the chemical environment
of pharmaceutical formulations, including mixtures, without changing or damaging
the sample. This allows us to investigate the desired properties of the actual product
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Figure 2-9: Illustrations of phase separated regions of API (gray) and polymer (white).
A. Phase separated regions are smaller than length scale L, solid solution; B. Phase
separated regions are as large or larger than length scale L, solid dispersion.
as it is in the final form.
Besides the relaxation time analysis used in this work, there are many other ap-
plications of solid state NMR, including two-dimensional NMR analysis that would
allow us to determine which functional groups of one molecule are interacting with
which functional groups in another [94]. Due to the low percentage of 13C in natural
abundance, these advanced techniques require 13C labeling in order to provide con-
clusive results. Though expense and time constraints currently limit the use of solid
state NMR, much research is being done to improve the signal-to-noise ratio without
needing 13C labeling [95-97], so it is only a matter of time before the technique is
efficient enough for widespread use in the pharmaceutical industry.
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Chapter 3
Methods
In this chapter we describe the methods used throughout the work this thesis, in-
cluding the materials selected, electrospinning equipment and parameters, scanning
electron microscopy, X-ray diffraction, differential scanning calorimetry, Fourier trans-
form infrared spectroscopy, solid state NMR, moisture content measurements with
thermogravimetric analysis, UV-visible spectroscopy, dissolution, and particle size
measurements.
3.1 Materials
3.1.1 Small Molecules
Aliskiren (SPP) was kindly supplied by Novartis AG. Indomethacin (IND), carba-
mazepine (CBZ), ibuprofen sodium salt (IBUss), famotidine (FAM), albendazole
(ABZ), ibuprofen (IBU), and lead (325 mesh) were purchased from Sigma-Aldrich
(St. Louis, MO).
3.1.2 Polymers
Poly(vinyl pyrrolidone) (PVP, 1.3 MDa M, and 55 kDa Mm), poly(ethylene oxide)
(PEO, 1 MDa Mm), poly(l-lactic acid) (PLLA, 259 kDa Mm), poly(acrylic acid) (PAA,
450 kDa Mm), poly(vinyl chloride) (PVC, 62 kDa M,), polycaprolactone (PCL, 10
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kDa M,) and polystyrene (PS, 280 kDa M,) were purchased from Sigma-Aldrich
(St. Louis, MO). Poly(methyl methacrylate) (PMMA, 300 kDa M") and nylon 3,6
(NY) were purchased from Scientific Polymer Products (Onterio, NY). Dry 1 pm and
3 pm polystyrene beads were purchased from Polysciences, Inc (Warrington, PA),
and dry 5 pm and 10 pm polystyrene beads were purchased from Microbeads AS
(Skedsmokorset, Norway).
3.1.3 Solvents
American Chemical Society grade ethanol (EtOH) and methanol (MeOH) were pur-
chased from VWR International (West Chester, PA). Dimethyl formamide (DMF),
chloroform, and tetrahydrofuran (THF) were purchased from Sigma-Aldrich (St.
Louis, MO).
3.2 Electrospinning
The single needle electrospinning apparatus (Figure 2-2) was arranged in a parallel
plate configuration and was equipped with a Harvard Apparatus PHD Infusion 2000
syringe pump and a Gamma High Voltage power supply model number ES30PN.
Table 3.1 shows the electrospinning parameters, including concentration, flow rate,
needle-to-ground distance and applied voltage for all materials electrospun on this
apparatus.
The free surface electrospinning experiments (Figure 2-3) were performed on a
custom-built apparatus complete with a Gamma High Voltage power supply model
number RR40-1.5R/DPPM and grounded collection plate covered in aluminum foil.
The wire spindle was constructed from 2 teflon disks of 3.2 cm diameter held 6.4
cm apart and connected with a center rod and wires at the outer edge. Either a
2-wire, where the wires were 1800 apart, or a 6-wire, where the wires were 600 apart,
configuration was used. The spindle was placed in the teflon solution bath and rotated
by a small DC motor (Zheng gear box motor ZGA25RP216). The entire apparatus
was located in an enclosure with low air flow. Both the wire electrode and the
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Name Polymer API Solvent Flow rate Distance Voltage
concentration concentration (mL/min) (in.) (kV)
1:4 SPP:PVP 10 wt% 2.5 wt% MeOH 0.03 9 24
1:2 SPP:PVP 10 wt% 5 wt% MeOH 0.02 9 24
1:1 SPP:PVP 10 wt% 10 wt% MeOH 0.02 9 24
4:1 SPP:PVP 6 wt% 24 wt% MeOH 0.02 9 20
1:1 IND:PVP 8 wt% 8 wt%* EtOH 0.04 9 28
2:1 IND:PVP 6 wt% 12 wt%* EtOH 0.05 9 28
1:1 IBU:PLLA 2.5 wt% 2.5 wt% Chloroform 0.03 11 30
1:1 CBZ:PLLA 3 wt% 3 wt% Chloroform 0.05 9 20
1:2 IBU:PMMA 7 wt% 3.5 wt% DMF 0.05 9 18
1:2 CBZ:PMMA 7 wt% 3.5 wt% DMF 0.05 9 18
1:2 IBU:NY 25 wt% 12.5 wt% DMF 0.03 9 23
1:2 CBZ:NY 25 wt% 12.5 wt%* DMF 0.08 9 27
1:2 IBU:PAA 5 wt% 2.5 wt% EtOH 0.2 9 13
1:2 CBZ:PAA 5 wt% 2.5 wt% EtOH 0.1 9 30
1:2 IBU:PVC 18 wt% 10 wt% 60% THF 0.1 9 27
40% DMF
1:2 CBZ:PVC 20 wt% 10 wt% 60% THF 0.03 9 26
40% DMF
1:2 IBU:PCL 8 wt% 4 wt% Chloroform 0.02 9 28
1:2 CBZ:PCL 8 wt% 4 wt% Chloroform 0.2 9 13
1:2 IBU:PS 20 wt% 10 wt% DMF 0.02 10.5 18
1:2 CBZ:PS 23 wt% 10 wt% DMF 0.05 9 12
1:2 IBU:PEO 2 wt% 1 wt% MeOH 0.2 9 15
1:1 CBZ:PEO 2 wt% 2 wt% MeOH 0.2 9 24
1:2 IBU:PVP 10 wt% 5 wt% MeOH 0.02 11 22
1:2 CBZ:PVP 10 wt% 5 wt% MeOH 0.02 9 19
Table 3.1: Electrospinning parameters for the formulations prepared using the single
needle apparatus discussed in this work, *heated in order to dissolve
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solution bath were connected to the high voltage supply [17]. For some electrospinning
experiments, the conductivity of the fluid was measured prior to spinning using a
VWR digital conductivity meter. The rotation rate of the wire spindle was set at 8.8
rpm, the electrode to ground distance was set at 20 cm, and the high voltage power
supplied to the bath was set to obtain jetting (approximately 30 kV) for all solutions
electrospun on the free surface apparatus.
3.3 Scanning Electron Microscopy
The morphology of the electrospun fibers was characterized by scanning electron
microscopy (SEM). The samples were sputter coated using a Quorum Technologies
SC7640 high resolution gold/palladium sputter coater and examined using a JEOL
6060 SEM at a 5 kV operating voltage. Where necessary, the fiber diameter was mea-
sured from the SEM images using ImageJ image analysis software (available through
the National Institutes of Health). At least 80 measurements were analyzed per sam-
ple, and the measurements were made from multiple images.
3.4 X-ray Diffraction
X-ray diffraction (XRD) was performed on a PANalytical X'Pert Pro instrument with
a reflection-transmission spinner PW 3064/60 sample stage and a Cu X-ray source
with a 1.54 A wavelength. For electrospun samples a piece of the mat was laid flat
on a zero background plate for analysis, and for powder samples the powder was
spread over the zero background plate and flattened with a microscope slide. Powder
patterns were taken of pure materials for comparison with electrospun samples.
The limit of detection for crystalline IND in a PVP matrix is approximately 1
wt% (Figure 3-1).
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Figure 3-1: XRD powder patterns of crystalline IND and physical mixtures of 5 wt%
crystalline IND in PVP, 1 wt% crystalline IND in PVP and 0.5 wt% crystalline IND
in PVP. Indicates limit of detection of crystalline IND by the XRD method used is
approximately 1 wt%.
3.5 Differential Scanning Calorimetry
DSC was performed on a TA DSC Q2000 instrument using a 2-6 mg sample in an alu-
minum sample pan. The materials were heated at 10'C/min from room temperature
to approximately 20*C beyond the melting point of the API present in the sample.
The limit of detection for IND in a PVP matrix is approximately 10 wt% (Figure
3-2).
For many of the formulations (including the IND/PVP mixtures in Figure 3-2),
a large, broad endotherm was present, centered around approximately 100*C. This
corresponds to the release of water absorbed by the SPP (where applicable) and
PVP [36], which has been confirmed by holding at 60*C for 2 hours to allow the water
to release prior to ramping the temperature in the DSC experiment. After such a
hold, there is no longer a broad endotherm in 50-150*C range, and these results are
shown in Figure 3-3. The 2 hour hold was used to measure the Tg of SPP/PVP
formulations (results in Section 4.2.2), but was not used in other experiments in this
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Figure 3-2: DSC curves of 5 wt% crystalline IND in PVP physical mixture, 10 wt%
crystalline IND in PVP physical mixture and pure crystalline IND. Indicates limit of
detection of crystalline IND in PVP by DSC is approximately 10 wt%.
work.
3.6 Fourier Transform Infrared Spectroscopy
Fourier transform infrared spectroscopy (FTIR) was performed with a Nicolet 8700
instrument (Thermo Fisher Scientific, Waltham, MA) and an Specac attenuated to-
tal reflectance (ATR) accessory (Specac, Slough, UK). Scans were pefrormed with
a 2 cm- 1 resolution, 128 scans, aperture of 69, gain of 8, and atmospheric suppres-
sion. The data was collected with and analyzed using the OMNIC software package
(Thermo Fisher Scientific, Waltham, MA).
3.7 Solid State Nuclear Magnetic Resonance
To measure domain size using solid state NMR, one uses the relaxation time constant,
a property of spin diffusion [31-35]. Like heat or mass, magnetization diffuses from
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Figure 3-3: DSC curves for 1:2 SPP:PVP electrospun formulations following a 2 hour
hold at 60 0C for the top curve, but no hold for the bottom curve.
areas of high magnetization to areas of low magnetization. The diffusion follows Fick's
law, Equation 2.2 [91].
By running experiments at different mixing times (i.e. diffusion times) and mea-
suring the maximum peak intensities, one can generate a plot of signal intensity vs.
mixing time. Figure 3-4 shows an example of experimental data for the T 1 ('H) of
the 1:1 SPP:PVP physical mixture. The filled symbols are the peak intensities for
the corresponding PVP peaks at each mixing time, T, and the open symbols are the
peak intensities for the corresponding SPP peaks at each mixing time, r. The peak
intensities have been normalized such that they fall between zero and one in order to
better show the difference in the exponential curves.
An exponential decay function of the form:
I(t) = I(O)exp (3.1)
can be fit to the intensity data for each peak, where I is the signal intensity, t is the
time and T is the relaxation time constant. For T 1 ('H) and T1 ,( 1 H) measurements,
t is the mixing time, or T. For the example case, the T, ('H) relaxation times for each
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Figure 3-4: Signal intensity vs. mixing time (T) from T1 (1 H) experiments for the 1:1
SPP:PVP physical mixture. Filled symbols correspond to PVP peaks, open symbols
correspond to SPP peaks.
peak are shown in Table 3.2.
There are two time constants that characterize the relaxation, T, (1 H) and T1 (1 H).
T 1 (1 H) characterizes domains on a larger length scale (20-80 nm) while T 1 ,( 1 H) char-
acterizes domains on a smaller length scale (2-20 nm), and the peak intensities from
two different experiments, inversion recovery (Figure 2-7) and spin lock (Figure 2-8),
are used to calculate each separately.
Immediately prior to solid state NMR experiments, electrospun mats were removed
from the desiccator and packed into a 4 mm rotor. The mats were not milled, but
placed in the rotor as is and packed tightly using a blunt rod. Approximately 40 mg
material was packed into the rotor.
Experiments were performed on a custom-built spectrometer operating at 500
MHz 1H Larmor frequency (courtesy of D. Ruben, FBML, MIT, Cambridge, MA),
equipped with a 4 mm triple-resonance Varian-Chemagnetics probe (Varian Inc., Palo
Alto, CA). The sample was cooled with a stream of dry air maintained at a temper-
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Material Peak (ppm) T1 (1H) (s)
PVP 175.7 2.52 ± 0.09
42.7 2.44 i 0.08
31.9 2.37 i 0.07
18.8 2.38 ± 0.08
SPP 148.5 1.39 t 0.17
112.9 1.47 i 0.22
69.7 1.35 ± 0.15
58.6 1.37 ± 0.17
30.7 1.31 ± 0.17
22.0 1.29 i 0.16
Table 3.2: T1 (1 H) values for each peak for the 1:1 SPP:PVP physical mixture
ature of 8*C, while the sample spinning speed at the magic angle was set to 10 kHz
for the SPP formulations and 8.5 kHz for the IND formulations. The spinning speeds
were chosen such that the spinning side bands did not overlap with the peaks of
interest. For all experiments, the 1H, 1 3 C, and 15N channel tuning and matching
were optimized, the spectra were referenced to adamantane, and the alignment of the
magic angle was verified.
One dimensional "C CP/MAS experiments were recorded using a CP contact
time of 2 ms and 100 kHz TPPM 1H decoupling during acquisition [98]. The relax-
ation delay, or the delay between scans, was 10 s for SPP formulations and 7 s for
IND formulations, which were the minimum to allow full return of the magnetization
to its original distribution. T1 (1H) was measured using an inversion recovery scheme
employing 100 kHz 1H pulses. The relaxation time was varied from 0 to 9000 ms for
the T 1('H) experiments. T1,( 1H) was measured using spin-lock experiments employ-
ing 100 kHz 1H pulses. The spin-lock time was varied from 1-35 ms and 1-60 ms for
SPP and IND formulations, respectively.
The free induction decays were Fourier transformed using software in the FBML
to obtain the intensity vs. chemical shift NMR spectra, and the resulting data was ex-
ported for further analysis following background correction and phasing. The FBML
software is not commercially available, but the Fourier transform operation, back-
ground correction, and phasing are standard in many NMR software packages, in-
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cluding those for Varian and Brucker instruments and NMRPipe, a unix-based free
software available through the National Institutes of Health. For background correc-
tion, the baseline was shifted up or down in order to set it to zero intensity and the
phasing was adjusted until the baseline was symmetric about the peaks. To decon-
volude overlapping drug and polymer peaks, MATLAB was used to fit the sum of the
pure amorphous spectra to the mixture spectrum in question.
The maximum peak intensities of the strong drug and polymer peaks were deter-
mined using the deconvoluded drug and polymer spectra, and the data for intensity
vs. mixing time (Figure 3-4) for each peak and each relaxation time (T1 (1 H) and
T1,('H)) were then fit to the exponential function in Equation 3.1 using built in
functions in Origin 8.5 (Table 3.2). We then calculated average T1 ('H) and T1,( 1H)
values for the drug and polymer using the four major PVP peaks (175.7, 42.7, 31.7,
and 18.8 ppm) and the six major SPP peaks (148.5, 112.9, 69.7, 58.6, 30.7, and 22.0
ppm) or six major IND peaks (156.5, 131.1, 113.9, 55.2, 29.9, and 13.3 ppm). For
the example case, with the 1:1 SPP:PVP physical mixture T1 (1 H), the average value
from the PVP peaks is 2.47 ± 0.20 s and the average value from the SPP peaks is
1.26 t 0.27 s.
3.8 Moisture Analysis
The weight percent water in electrospun stability samples was measured using ther-
mogravimetric analysis (TGA). TGA experiments were performed on a TA TGA
Q5000 (TA Instruments, New Castle, DE). A ramp of 20*C/min to 150*C was used
and the weight percent water was calculated from the weight loss between 40-110*C
using the TA Universal Analysis software (TA Instruments, New Castle, DE).
3.9 UV-visible Spectroscopy
In order to determine the actual drug loading in electrospun fibers, samples were
analyzed with a Perkin-Elmer (Waltham, MA) double-beam Lambda25 UV-vis spec-
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trophotometer. A standard curve was prepared for ABZ in methanol for concentra-
tions from 0.005 mg/mL to 0.05 mg/mL at an absorbance of 295 nm and for FAM in
methanol for concentrations from 0.002 mg/mL to 0.035 mg/mL at an absorbance of
286 nm. PVP does not absorb in the UV range and pure methanol was used for the
background spectrum. A known mass of electrospun mat was dissolved in a known
volume of methanol and diluted such that the expected concentration of API fell
within the concentration ranges covered by the standard curves. From the resulting
measured concentration, the mass of API in the original mat sample, and thus the
weight percent API in the electrospun mat was calculated. Three measurements were
made per API and were averaged to give the reported value.
3.10 Dissolution
Tablets were made from electrospun material by weighing out 150 mg of the fiber
mat and pressing into a 9 mm tablet using a Gamlen Tablet Press model GTP1 in
the manual mode. The material was inserted into the die randomly, it was not rolled
or folded in a controlled manner. Powder tablets were prepared by weighing out 50
mg API powder and 100 mg PVP powder, mixing for 1 min, and pressing into 9 mm
tablets using the same press with the same insertion depth.
Dissolution was performed using a Varian VK 7025 dissolution bath (Agilent,
Santa Clara, CA) and a Cary 50 Bio UV spectrophotometer (Agilent, Santa Clara,
CA). For ABZ we used the standard United States Pharmacopeia (USP) method with
900 mL 0.1 N HCl media, apparatus II, 50 rpm paddle speed and a temperature of
37*C. For FAM we used the standard USP method with 900 mL 0.1 M Phosphate
buffer media, apparatus II, 50 rpm paddle speed, and a temperature of 37*C. Three
tablets of each formulation were tested and the average is reported. Measurements
were made every minute for 90 minutes by probes inserted into the bath and connected
to the spectrophotometer by fiber optic cables.
61
3.11 Particle Size Measurement
Particle size analysis was performed on the applicable spinning solutions prior to
sonication, after sonication, and 1 hour after sonication. A Malvern Mastersizer 2000
with a Hydro 2000pP accessory was used to measure the particle size distribution and
the volume-based results were used for the analysis. Three measurements were made
per sample and the average is reported in this work.
62
Chapter 4
Electrospinning of Fibers
Containing Amorphous API
4.1 Introduction
In this chapter, solid state NMR is used to measure the spin lattice relaxation times for
1:1 SPP:PVP, 4:1 SPP:PVP, 1:1 IND:PVP, and 2:1 IND:PVP formulations prepared
by electrospinning in order to determine whether the APIs and PVP are well-mixed
down to small length scales (Section 4.2.3). As supporting evidence, the Tg of the
mixture was determined for SPP/PVP mixtures and compared to that predicted by
the Gordon-Taylor equation (Section 4.2.2).
Two other formulations were studied using solid state NMR relaxation times. The
first was a 4:1 SPP:PVP solid dispersion prepared by hot melt extrusion, which was
used to compare electrospinning to a second method of forming solid dispersions. A
2:1 IBUss:PVP electrospun formulation was also analyzed because it partially crys-
tallized during electrospinning, allowing us to verify that phase separation could be
determined by solid state NMR relaxation time analysis.
This study also applies solid state NMR relaxation time analysis to investigate
the homogeneity of the solid solutions over 6 mo., and these results are presented in
Section 4.3. Since physical stability is enhanced in a solid solution, it is desirable that
the two components remain intimately mixed over a typical shelf life, preventing an
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opportunity for crystallization. We also use FTIR to probe the interactions between
SPP-PVP and IND-PVP and determine whether interactions contribute to stability
in addition to the decreased mobility due to the high mixing level.
4.2 Results and Discussion: Homogeneity of the
API/Polymer Solid Mixture
Electrospinning was used to prepare solid dispersions of unknown mixing level of a
polymer, PVP, with either SPP, IND, or IBUss. The water-soluble polymer PVP
was chosen as the excipient because it is known to hydrogen bond with many APIs,
including IND [25], and it has a high Tg, so will act as a strong antiplasticizer. SPP
was chosen as one model compound because it will only crystallize in the presence of
certain solvents, allowing us to investigate a case where only phase separation and not
crystallization would occur. The second API, IND, was chosen due to its ability to
remain amorphous during the 1 week NMR analysis time for the pure sample, but still
crystallize over time under some conditions. IBUss was chosen to demonstrate that
solid state NMR relaxation time analysis can show when phase separation occurs in
electrospun samples, as IBUss is partially crystalline following electrospinning. The
T1 (1H) and T1,( 1H) relaxation times were measured for 1:1 SPP:PVP, 4:1 SPP:PVP,
1:1 IND:PVP, 2:1 IND:PVP, and 2:1 IBUss:PVP electrospun formulations, as well as
a 4:1 SPP:PVP extruded formulation. In addition, the glass transition temperature
for the mixture was determined for SPP formulations and compared to that predicted
by the Gordon-Taylor equation.
4.2.1 Morphology of Electrospun Fibers
The morphology of electrospun fibers containing amorphous API and polymer was
examined using SEM. In particular, we used SEM micrographs to verify that we
obtained smooth fibers without any beads or protrusions. The micrographs are shown
in Figure 4-1.
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Figure 4-1: SEM images of electrospun A. 1:1 SPP:PVP, B. 4:1 SPP:PVP, C. 1:1
IND:PVP, and D. 2:1 IND:PVP
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4.2.2 Glass Transition Temperature and the Gordon-Taylor
Equation
The glass transition temperature has often been used as an indicator of miscibility
of multiple components in a mixture [8, 26,99]. For a two component system, well-
mixed materials will exhibit only one Tg for the mixture, whereas phase separated
materials will exhibit two Tgs. For an ideal system with no interaction between the
components, the Tg of the homogeneous mixture can be predicted by the Gordon-
Taylor equation [26]:
w1Tg1 + Kw 2Tg2  (4.1)
w1 + Kw 2
where wi and w2 are the weight fractions of components 1 and 2, Tgi and Tg2 are the
glass transition temperatures of components 1 and 2, and K is p1T1/P2Tg2, where pi
and P2 are the densities of components 1 and 2. Though only sensitive to a domain
size of approximately 30 nm, the technique is a simple method to determine whether
an API and polymer in a solid mixture are phase separated [8,27].
To examine the use of this method, we measured the Tg for various SPP/PVP
electrospun mixtures (Figure 4-2). We did not include results for SPP drug loadings
above 50% because the degradation of SPP occurs in the same temperature range as
the expected Tgs and the DSC scans are not smooth enough in that region at high
loadings to conclusively determine a Tg. The spikes in the DSC cures for the pure
PVP and 1:2 SPP:PVP samples are due to instrument error and the non-smooth
character of the curve above 150*C for the 1:1 SPP:PVP is due to SPP degradation
at high temperatures. From these results we see that only one Tg is present for each
of the mixtures, indicating that the SPP and PVP are in close contact and likely a
homogeneous solid solution.
Figure 4-3 shows a comparison of the measured Tgs to the Tgs calculated using
the Gordon-Taylor equation and assuming that the density of the amorphous SPP
is equal to the density of the amorphous PVP. The calculated and measured Tg
values are quite close for all three mixtures, indicating that, if interactions between
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Figure 4-2: DSC curves for electrospun SPP formulations with glass transition tem-
peratures labeled; A. PVP, B. 1:4 SPP:PVP, C. 1:2 SPP:PVP, D. 1:1 SPP:PVP, and
E. Amorphous SPP
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Figure 4-3: Comparison of measured glass transition temperatures (filled circles) with
those calculated from the Gordon-Taylor equation (open squares)
the SPP and PVP are present, they are of the same order of magnitude as SPP-SPP
interactions and PVP-PVP interactions, allowing the volume additivity assumption
of the Gordon-Taylor equation to hold.
The Tg of the IND/PVP mixtures was too weak to be measured for most cases, so
a similar study could not be done with the electrospun IND formulations. However,
due to enthalpy relaxation [70], the signal for the Tg of the 2:1 IND:PVP was strong
enough to measure after 6 months of storage at 40*C and was found to be 81'C. Using
the Gordon-Taylor equation, the Tg of pure IND from the literature, 42*C [100], and
again making the assumption that the densities of the two materials are equal, the
calculated Tg is 56*C. In this case, the measured and calculated Tgs are different,
indicating that there are likely significant interactions between the IND and the PVP
in the mixture (the interactions will be discussed further in Section 4.3.3).
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Figure 4-4: Solid state NMR spectra for amorphous SPP, amorphous IND and PVP
4.2.3 Solid State Nuclear Magnetic Resonance Analysis of
Phase Separation
One dimensional 13C solid state NMR spectra were obtained for amorphous SPP, IND,
and PVP (Figure 4-4). From these spectra, we were able to identify the strongest
peaks for the materials (Table 4.1). The peaks at 198.7 and 63.9 ppm for IND are
spinning side bands. Peaks in the 170 ppm range were not included for IND or
SPP because the intensity was too low to analyze at many time points. T 1 (1H) and
T 1 ,( 1H) were measured for each of these peaks for the pure materials and the error
was determined using the uncertainty in the exponential fit. They are listed in Table
4.1.
The T 1 (1 H) and T1 ,( 1 H) values vary slightly from one peak to another for each
compound. To account for this variance when performing the deconvolution fitting,
spectra of the pure components from the time point closest to that for the mixture
being analyzed were used for deconvolution.
The T 1 (1 H) and T 1 ,( 1 H) relaxation times were measured for pure compounds,
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Material Peak (ppm) T1 (1 H) (s) T1,('H) (ms)
PVP 175.7 2.33 ± 0.60 20.9 ± 0.6
42.7 2.30 ± 0.66 20.7 ± 0.5
31.9 2.41 ± 0.82 20.1 i 0.4
18.8 2.37 ± 0.83 21.3 i 0.6
SPP 148.5 1.07 t 0.41 8.8 t 0.3
112.9 1.02 i 0.53 9.7 i 0.8
69.7 1.05 ± 0.29 8.5 ± 0.2
58.6 1.07 ± 0.29 8.6 ± 0.4
30.7 1.05 ± 0.29 8.4 i 0.2
22 1.05 ± 0.25 8.3 ± 0.2
IND 156.5 2.61 t 0.16 34.4 ± 2.0
131.1 2.53 ± 0.15 38.2 ± 2.3
113.9 2.51 i 0.13 38.4 ± 2.7
55.2 2.53 + 0.15 31.2 t 2.1
29.9 2.57 ± 0.13 34.1 i 2.1
13.3 2.63 ± 0.15 33.4 + 2.3
Table 4.1: T1 (1 H) and T1 ,( 1 H) for the major peaks of PVP, SPP, and IND
physical mixtures, electrospun formulations and an extruded formulation, and they
are reported in Table 4.2. The relaxation times reported for the mixtures are the
averages of the PVP peaks (top number) and of the API peaks (bottom number). The
reported uncertainty is determined from the largest deviation from the average using
the uncertainty from the exponential fits. In the cases where the average relaxation
time from the PVP peaks is within the uncertainty of the average relaxation time
from the API peaks, no minimum domain size was calculated, and where there was a
difference in the relaxation times, the minimum domain size is listed in Table 4.2.
The T1('H) and T1,('H) relaxation times can be correlated to a length scale
of phase separation. In time T1 (1 H) or T1,( 1H), diffusion occurs across a length, L,
which can be calculated from the diffusion coefficient D and the relaxation time T [91]
using Equation 2.3. In calculating the length scale, the diffusion coefficient plays an
important role. However, it is not practical to measure a diffusion coefficient for the
particular materials under consideration, as we are not able to prepare a sample with
a known domain size. Two diffusion coefficients are commonly used in the literature,
8.0 x 10-16 m2 /s for rigid systems [92] and 0.5 x 10-16 m2 /s for mobile systems [91].
70
Formulation T1 ('H) (s) Minimum Tip(1 H) (ms) Minimum
domain size domain size
SPP 1.05 ± 0.08 NA 8.7 ± 1.8 NA
PVP 2.37 ± 0.15 NA 20.7± 1.1 NA
IND 2.56 ± 0.22 NA 35.0 ± 6.1 NA
Amorph. 1:1 SPP:PVP 2.47 ± 0.20 20-110 nm 23.6 ± 1.8 2-11 nm
Physical Mixture and and
1.26 ± 0.27 12.6 ± 3.7
Amorph. 1:1 IND:PVP 2.44 ± 0.24 30-110 nm 18.8 ± 0.5 2-11 nm
Physical Mixture and and
2.67 ± 0.43 29.8 ± 6.3
1:1 SPP:PVP 1.56 t 0.10 NA 11.1 ± 0.3 NA
Electrospun and and
1.40 ± 0.29 9.9 ± 1.7
1:1 IND:PVP 2.11 ± 0.17 NA 29.2 ± 2.3 NA
Electrospun and and
2.15 ± 0.32 28.9 ± 4.2
4:1 SPP:PVP 2.27 ± 0.21 20-100 nm 12.4 ± 0.63 2-8 nm
Extruded and and
1.32 ± 0.20 9.0 ± 1.4
4:1 SPP:PVP 1.31 i 0.09 NA 8.3 ± 0.3 NA
Electrospun and and
1.33 ± 0.25 7.9 ± 1.0
Table 4.2: Relaxation time constants for SPP/PVP and IND/PVP formulations; the
top number in mixtures is measured from the PVP peaks and the bottom number is
measured from the API peaks, NA = No separated domains
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In this work, L is calculated using both diffusion coefficients and is presented as a
range.
For the SPP/PVP amorphous physical mixtures, the relaxation times measured
from the SPP and PVP peaks were different for both T1 (1 H) and T1,( 1 H), with
corresponding minimum domain sizes of 20-110 nm and 2-11 nm, respectively. For
the electrospun 1:1 SPP:PVP formulation, the relaxation times calculated from the
SPP and PVP peaks were within experimental error of each other, meaning that the
components were well mixed down to a length scale of 2-11 nm and indicating that
the electrospun formulation is a solid solution down to these length scales.
For the IND/PVP formulations, there was no difference in the T1 (1H) values
within the experimental uncertainty for either the physical mixture or the electro-
spun formulation. This is to be expected, as the values for the pure amorphous IND
and PVP are 2.56 t 0.22 s and 2.37 + 0.15 s, respectively, which are within exper-
imental uncertainty of each other. For the T1,( 1H), on the other hand, the values
for the pure components are 35.0 + 6.1 ms and 20.7 t 1.1 ms, respectively, which
are sufficiently different. For the 1:1 IND:PVP physical mixture, the T1,( 1 H) val-
ues measured from the IND and PVP peaks differed, whereas for the 1:1 IND:PVP
electrospun formulation, the T1,( 1 H) values calculated for the IND and PVP peaks
were equal within experimental error. With a calculated domain size of 2-11 nm, it is
clear from these results that the electrospun formulation is a solid solution down to
a length scale of 2-11 nm.
To demonstrate that electrospinning is a strong technique for forming solid so-
lutions, we compared it to hot melt extrusion, a technique commonly used to form
solid solutions or dispersions [1,101]. We performed the relaxation time analysis on
a 4:1 SPP:PVP mixture prepared by hot melt extrusion and a 4:1 SPP:PVP mixture
prepared by electrospinning. For the extruded formulation, two significantly different
values were measured for both the T 1('H) and T1,( 1 H), indicating that there was
separation of the SPP and PVP with domain sizes greater than 20-100 nm. For the
electrospun formulation, the two measured values for both the T1 (1H) and T1,('H)
were within experimental uncertainty, indicating that the drug and polymer are well-
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Figure 4-5: XRD powder patterns of electrospun 2:1 IBUss:PVP and crystalline
IBUss.
mixed on a domain size of 2-11 nm or less. The reason for this difference in mixing
levels is due to a key difference in the processes. For extrusion, the SPP and PVP
begin as separate powders and are gradually mixed near the melting point of SPP
(but below the Tg of PVP), making it difficult to form a molecular-level mixture.
Electrospinning, on the other hand, begins with a well dispersed solution of solvent
with the SPP and PVP and the solvent is removed through rapid evaporation, making
it difficult for the SPP and PVP to phase separate.
This study was further extended to examine a partially amorphous formulation,
2:1 IBUss:PVP, in order to demonstrate that phase separation can occur with electro-
spinning and that it can be measured using the solid state NMR techniques applied
here. When electrospun in a ratio of 2 to 1 drug to polymer, the IBUss is partially
crystalline in the fibers, as can be seen from XRD powder pattern in Figure 4-5.
Solid state NMR was performed on the electrospun samples and the NMR spec-
trum with primary peaks numbered is shown in Figure 4-6. These peaks were chosen
for analysis because they remained clearly non-overlapping for all mixing times.
Table 4.3 lists the values of T 1 (1 H) and T1 ,( 1 H) measured for each peak labeled in
Figure 4-6. For the T1 (1H) values, a slight difference is seen in those measured from
the PVP peaks (average of 1.04 i 0.07 s) and those measured from the IBUss peaks
73
0
S
150 100 50 0
Chemical Shift (ppm)
Figure 4-6: Solid state NMR spectrum of electrospun 2:1 IBUss:PVP.
Table 4.3: Relaxation time constants for 2:1 IBUss:PVP for each peak labeled in
Figure 4-6.
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Peak T1 ('H) T1 ,( 1H)
PVP1 1.04 i 0.06 s 11.2 ± 0.5 ms
PVP2 1.07 t 0.04 s 11.6 ± 0.3 ms
PVP3 1.01 i 0.04 s 11.2 ± 0.3 ms
IBUss1 0.90 ± 0.03 s 4.7 t 0.2 ms
IBUss2 0.89 ± 0.04 s 5.2 ± 0.3 ms
IBUss3 0.88 ± 0.03 s 6.1 t 0.2 ms
IBUss4 0.91 t 0.03 s 6.8 t 0.1 ms
IBUss5 0.88 t 0.02 s 6.6 t 0.1 ms
(average of 0.89 i 0.04 s). This indicates that there is phase separation between the
PVP and IBUss of the domain size 20-90 nm or larger, as is expected given that the
IBUss is partially crystalline. For the T1,(1 H) values, the difference in the T1,(1 H)
between the PVP and IBUss is larger, with the average T1,(1 H) for the PVP peaks
being 11.3 ± 0.6 ms and for the IBUss being 5.9 ± 1.0 ms. Therefore, the conclusion
of phase separation in this sample is further supported by the T1,( 1 H) data, and we
know that electrospinning can produce phase separated solid dispersions and solid
state NMR can be used to identify them.
4.2.4 Summary
From the results of the solid state NMR relaxation time studies reported above, we
can conclude that 1:1 electrospun formulations of SPP or IND with PVP, as well as
4:1 SPP:PVP and 2:1 IND:PVP are miscible to a length scale of 2-10 nm immediately
after electrospinning. This illustrates the potential of electrospinning to be used to
make solid solutions for final solid dosage forms. For SPP, this conclusion is supported
by the measurement of only one Tg for the electrospun mixtures.
A 2:1 IBUss:PVP formulation was used to demonstrate that the solid state NMR
relaxation time analysis will show the presence of phase separation when the com-
ponents are not intimately mixed. IBUss is partially crystalline in the formulation
studied, and both T1(1 H) and T1,( 1 H) measurements showed that the IBUss and
PVP were phase separated.
We have also shown that a 4:1 SPP:PVP electrospun formulation is miscible to the
2-10 nm domain size, whereas a 4:1 SPP:PVP extruded formulation is phase separated
with domain sizes of 20-100 nm or larger. The impact of this is two-fold. First, it
shows that solid state NMR can be used to compare the phase separation in different
solid dosage forms when the products appear similar using other techniques. Second,
it shows that electrospinning a drug and polymer from a solution forms solid solutions
at a high drug loading and can be a useful process for formulating amorphous API.
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4.3 Results and Discussion: Physical Stability of
Amorphous API in Electrospun Fibers
Typical physical stability studies of pharmaceutical products involve storage at high
temperatures and/or high humidity and analysis via XRD and DSC to determine
crystallinity as a function of time [36]. Solid state NMR has also been used in sta-
bility studies to examine crystallization over time. Crystallinity of an API has been
evaluated using solid state NMR at late time points [102, 103], which was advan-
tageous over XRD or DSC due to the increased sensitivity of solid state NMR for
detecting crystalline material and crystal defects.
In this section, we apply solid state NMR relaxation time analysis to investigate
the homogeneity of solid solutions over time, rather than only examining the crystal-
lization of the API over time. Since physical stability is enhanced in a solid solution, it
is desirable that the two components remain intimately mixed over a typical shelf life,
preventing an opportunity for crystallization. Stability can also be enhanced when the
amorphous API and polymer excipient are able to interact. In this section, we utilize
FTIR spectral analysis to identify hydrogen bonding in the electrospun formulations.
Extending the solid state NMR study from Section 4.2, the T1 (1 H) and T1,(1 H) re-
laxation times were measured for 1:1 SPP:PVP, 4:1 SPP:PVP, 1:1 IND:PVP and 2:1
IND:PVP formulations after 0 mo., 3 mo., and 6 mo. storage at 40*C and 0% relative
humidity (RH) to determine the physical stability of the solid solution. As support-
ing evidence, we also used XRD and DSC to verify that no crystallization occurred
during the 6 mo. analysis period.
4.3.1 Moisture Analysis
It is well known that water acts as a plasticizer and increases mobility of components
in a solid dispersion [104]. Due to the increased mobility, this can also cause the
relaxation times measured in solid state NMR to decrease [105, 106]. In order to
remove the known effect of water on mobility and the relaxation times, we stored our
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Sample Weight Percent Water
1:1 SPP:PVP 3 mo. 1.2
1:1 IND:PVP 3 mo. 1
4:1 SPP:PVP 3 mo. 1.1
2:1 IND:PVP 3 mo. 1.1
1:1 SPP:PVP 6 mo. 3.5
1:1 IND:PVP 6 mo. 0.2
4:1 SPP:PVP 6 mo. 1.3
2:1 IND:PVP 6 mo. 0.2
Table 4.4: Weight percent water in stability samples as measured by TGA
Sample Weight Percent Water
1:1 SPP:PVP 1.7
1:1 IND:PVP 1.8
4:1 SPP:PVP 1.1
2:1 IND:PVP 2.0
Table 4.5: Weight percent water in electrospun samples as measured immediately
after electrospinning by TGA
samples in a desiccator with a humidity of less than 5% RH in the stability chamber.
Prior to solid state NMR analysis of the 3 mo. and 6 mo. samples, we measured the
weight percent water present in the fibers in order to confirm that water was not the
key factor affecting the measured relaxation times (Table 4.4). The weight percent
water was not measured for initial samples because previous tests, whose results are
shown in Table 4.5, showed approximately 1-2 wt% water when spun in the controlled
humidity environment of the lab.
As can be seen in Table 4.4, for all cases the water content is generally low, so the
effect of water on the relaxation times should be minimal. The 1:1 SPP:PVP sample
measured after 6 mo. storage had slightly high water content, which was due to the
analysis being carried out over multiple days and the sample being exposed to high
humidity.
4.3.2 Stability of the Amorphous Form
DSC and XRD experiments were performed on all samples in order to determine
whether crystalline API was present in the fibers. For IND, the limit of detection
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Figure 4-7: DSC curves for 1:1 SPP:PVP and 4:1 SPP:PVP at 0, 3, and 6 mo. For
scale reference, the depth of the SPP crystalline melting endotherm is approximately
0.5 W/g.
for DSC is 10 wt% crystalline material and for XRD is 1 wt% crystalline material;
demonstration of these limits may be found in Figures 3-2 and 3-1, respectively. SPP
will not crystallize unless in the presence of specific solvents, so will not crystallize
over time in our system. The DSC curves for SPP formulations are shown in Figure
4-7, while those for the IND formulations are shown in Figure 4-8.
For scale reference, the depth of the crystalline IND endotherm is approximatley
6 W/g and the depth of the crystalline SPP endotherm is approximately 0.5 W/g.
The crystalline IND standard peak was obtained by testing the crystals as-received,
and is assumed to correspond to 100% crystalline material. For SPP, the crystalline
standard peak was also obtained by testing the crystals as-received from Novartis.
The material is not 100% crystalline, but is approximately 85% crystalline. None of
the DSC curves for the SPP/PVP or IND/PVP formulations show endotherms in the
range of the melting peak measured from the crystalline standards, indicating that
neither SPP nor IND is crystalline in the fibers for any sample.
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Figure 4-8: DSC curves for 1:1 IND:PVP and 2:1 IND:PVP at 0, 3, and 6 mo. For
scale reference, the depth of the crystalline IND melting endotherm is approximately
6 W/g.
All of the DSC curves for the SPP formulations display a broad endotherm at low
temperatures. This endotherm corresponds to the release of water absorbed by the
SPP and PVP [36], as was discussed in Section 3.5. This same endotherm is also
present in the 1:1 IND:PVP 3 mo. sample. For many of the SPP formulations, there
are also disturbances in the curve at temperatures above 110*C, which are due to
chemical degradation of the SPP at those temperatures.
The XRD powder patterns for the SPP formulations are shown in Figure 4-9 and
the XRD powder patterns for the IND formulations are shown in Figure 4-10.
All formulations of SPP/PVP and IND/PVP at all times show an amorphous
hump and no defined peaks. This indicates that there is no detectable crystalline
drug present in the fibers. The 1:1 IND:PVP 6 mo. and 2:1 IND:PVP 6 mo. sam-
ples (Figure 4-10-D and -G) were measured on a different instrument than the other
samples, hence the sloped curve at low values of 2-theta.
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Figure 4-9: XRD powder patterns for A. Crystalline SPP, B. 1:1 SPP:PVP at 0 mo.,
C. 1:1 SPP:PVP at 3 mo., D. 1:1 SPP:PVP at 6 mo., E. 4:1 SPP:PVP at 0 mo., F.
4:1 SPP:PVP at 3 mo., G. 4:1 SPP:PVP at 6 mo.
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Figure 4-10: XRD powder patterns for A. Crystalline IND, B. 1:1 IND:PVP at 0 mo.,
C. 1:1 IND:PVP at 3 mo., D. 1:1 IND:PVP at 6 mo., E. 2:1 IND:PVP at 0 mo., F.
2:1 IND:PVP at 3 mo., G. 2:1 IND:PVP at 6 mo.
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Figure 4-11: Chemical structures of IND, SPP, and PVP
4.3.3 Interactions Between API and Excipients
As mentioned in Section 2.3.1, close contact between an API and excipient can lead to
hydrogen boonding interactions, which can stabilize an amorphous API. This has been
demonstrated for CBZ and hydroxypropyl methylcellulose (HPMC) [107], felodipine
and PVP [24], felodipine and HPMC [24], and IND and PVP [25], among others. We
investigated the interactions for three of the electrospun formulations discussed here,
1:1 IND:PVP, 2:1 IND:PVP, and 1:1 SPP:PVP. The chemical structures of IND, SPP,
and PVP are shown in Figure 4-11.
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Figure 4-12: FTIR spectra of PVP, 1:1 IND:PVP electrospun, 2:1 IND:PVP electro-
spun, and amorphous IND
Solid dispersions of IND/PVP prepared by solvent evaporation with a rotary evap-
orator were studied previously [25]. It was found that there is a peak for PVP at
1679 cm- 1 corresponding to the vibrations of the amide carbonyl when not hydrogen
bonded, a peak for amorphous IND at 1710 cm- 1 corresponding to the vibrations of
the carboxylic acid when IND is present as hydrogen bonded dimers and a peak for
solid dispersions at 1726 cm- 1 corresponding to the vibrations of the IND carboxylic
acid when hydrogen bonded with PVP [25].
Figure 4-12 shows the FTIR spectrum for IND formulations in the 1500-1900
cm- 1 range. In both the 2:1 and 1:1 IND:PVP electrospun formulations, the peak
at approximately 1710 cm- 1 disappears (it is present in the amorphous IND at 1706
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cm- 1 ) and the peak at approximately 1723 cm-1 (corresponding to the peak at 1726
cm- 1 in [25]) appears for both samples. This indicates that the amorphous IND in
the fibers no longer exists as cyclic dimers, but instead is hydrogen bonded with PVP.
SPP is a more complicated molecule and much of the FTIR spectrum is difficult
to interpret due to overlapping peaks, particularly in the 1500-1900 cm- 1 range. One
area that can be examined is 500-1200 cm-1, where the C-N vibrations, 0-H vibra-
tions, and ring and C-H deformation vibrations for the aromatic ring occur. These
functional groups could all interact in with PVP, and so would change if interac-
tions occurred. The spectra for SPP, PVP and the 1:1 SPP:PVP physical mixture
are shown in Figure 4-13, and the spectra for SPP, PVP and the 1:1 amorphous
SPP:PVP electrospun are shown in Figure 4-14.
If interactions were occurring between SPP and PVP, one would expect changes
in the FTIR peaks for the functional groups participating in the interactions. In
Figure 4-13, the spectrum of the 1:1 SPP:PVP amorphous physical mixture is nearly
identical to that of SPP, which is to be expected, as the spectrum would be a sum
of the SPP and PVP spectra for a physical mixture and the PVP barely absorbs in
this range. For the 1:1 SPP:PVP electrospun sample, there is less definition in the
peaks, but the strong peaks (those labeled in Figure 4-14) remain and do not shift
significantly. Thus, there is no clear evidence of interactions. However, because there
is still a difference between the electrospun and physical mixture spectra, interactions
cannot be conclusively ruled out based on these results.
4.3.4 Stability of the Solid Solution
Solid state NMR T1 (1 H) and Tip( 1H) measurements were made of pure components,
physical mixtures and the electrospun formulations at the storage times of 0, 3, and
6 mo., and they are reported in Table 4.6. The reported times are the averages for
the PVP peaks (top number) and API peaks (bottom number). The uncertainty is
determined from the largest deviation from the average using the raw values and the
uncertainty in the exponential fits.
Both the T1 (1 H) and T1,(1 H) relaxation times for the pure amorphous SPP and
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Figure 4-13: FTIR of PVP (bottom), SPP (middle), and 1:1 SPP:PVP amorphous
physical mixture (top) with peaks for vibrations of important functional groups
marked.
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Formulation T1 ('H) (s) T1 (1 H) (s) T1 ( H) (s) T1 ( H) (ms) T1 ,(1 H) (ms) T1p(H) (ms)
0 months 3 months 6 months 0 months 3 months 6 months
SPP 1.05 ± 0.08 NA NA 8.7 1.8 NA NA
IND 2.56 ± 0.22 NA NA 35.0 6.1 NA NA
PVP 2.37 t 0.15 NA NA 20.7 ± 1.1 NA NA
Amorphous 1:1 SPP:PVP 2.47 t 0.20 NA NA 23.6 1.8 NA NA
Physical Mixture 1.26 ± 0.27 12.6 t 3.7
Amorphous 1:1 IND:PVP 2.44 ± 0.24 NA NA 18.8 ± 0.5 NA NA
Physical Mixture 2.67 ± 0.27 29.8 ± 6.3
1:1 SPP:PVP 1.54 ± 0.14 1.48 ± 0.10 1.60 ± 0.10 11.2 t 0.9 9.7 ± 0.7 7.1 ± 0.6
Electrospun 1.36 ± 0.16 1.29 ± 0.21 1.29 t 0.31 10.3 ± 3.5 9.7 ± 3.2 5.9 t 1.7
1:1 IND:PVP 2.44 ± 0.21 2.51 ± 0.20 2.45 ± 0.18 16.8 ± 1.2 15.3 ± 1.0 16.9 ± 1.0
Electrospun 2.48 t 0.26 2.37 ± 0.43 2.42 ± 0.19 15.8 + 2.2 14.2 ± 2.2 17.2 ± 1.8
4:1 SPP:PVP 1.34 ± 0.24 1.25 ± 0.19 1.17 ± 0.11 8.2 t 1.1 7.8 ± 0.5 9.3 ± 1.2
Electrospun 1.35 ± 0.28 1.13 ± 0.12 1.08 ± 0.11 7.6 ± 1.1 8.0 ± 1.5 9.4 ± 2.1
2:1 IND:PVP 2.19 ± 0.24 2.46 ± 0.23 2.28 t 0.17 33.5 ± 5.8 34.2 ± 3.5 40.5 ± 12.4
Electrospun 2.20 ± 0.23 2.55 ± 0.29 2.33 ± 0.32 34.7 + 7.3 38.1 ± 7.1 48.0 ± 16.2
Table 4.6: Relaxation time constants for stability studies,
is from the drug peaks. NA = No separated domains
top number in mixtures is from the polymer peaks and bottom number
oo0
PVP are sufficiently different to distinguish between them. This is demonstrated by
the amorphous 1:1 SPP:PVP physical mixture, where the T1 (1 H) and T1,( 1 H) values
as measured from the PVP peaks differed from those measured from the SPP peaks.
For IND, however, the T1 (1H) values were not sufficiently different to distinguish; 2.37
i 0.15 s and 2.56 ± 0.22 s are within the experimental error of each other. Thus, the
analysis of the IND formulations was based only on the T1,( 1 H) values.
For both the 1:1 SPP:PVP and 4:1 SPP:PVP electrospun formulations, the T 1('H)
values measured from the PVP peaks are within experimental error of the T1 (1 H)
value measured from the SPP peaks. The domain size associated with these values
can be calculated using Equation 2.3. We report the domain size as a range using
each diffusion coefficient discussed previously (Section 4.2.3). For the T1 (1 H) values
measured from the SPP/PVP formulations, we conclude that the materials are ho-
mogeneous to a domain size of 20-80 nm and remain as such throughout the 6 mo.
stability study.
The T1,( 1H) relaxation times for the SPP/PVP formulations measured from the
SPP and PVP peaks also remain within experimental error of each other throughout
the 6 mo. study period. This indicates that the materials are in a solid solution with
no phase separation of 2-10 nm or greater. The 6 mo. sample for the 1:1 SPP:PVP
has lower values of the T1,( 1 H) than the 0 mo. or 3 mo. sample, which is likely due
to its higher water content, approximately 3.5 wt% versus 1.1 wt%.
For the IND formulations, the T1,(1 H) values remain within experimental error
of each other, indicating that the solid solutions retain their homogeneity down to a
2-10 nm domain size for the entire 6 mo. storage period. The value of the T1,(1 H)
increases significantly from the 3 mo. sample to the 6 mo. sample. This may be due
to the decrease in the water content (1.1 wt% to 0.2 wt%) and subsequent increase
in the Tg from approximately 75*C to 80'C, which can be seen in Figure 4-8. The
T1,( 1 H) values measured for the 2:1 IND:PVP formulation have a large experimental
error associated with them, which is because the T1,( 1 H) is large and experiments
could not be run for long enough spin-lock times to allow the signal to decrease to
zero, as they could for the other formulations. This experimental limit, due to a limit
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in the amount of time a high power could be applied in the NMR, required us to
calculate a T1,( 1 H) value from an incomplete exponential curve, resulting in greater
error.
4.3.5 Summary
Solid state NMR relaxation time measurements were used to study the stability of
solid solutions prepared by electrospinning over 6 mo. at an elevated temperature.
It was found that for all four formulations studied, 1:1 SPP:PVP, 4:1 SPP:PVP, 1:1
IND:PVP and 2:1 IND:PVP, the mixture remained homogeneous down to a 2-10
nm domain size throughout the study period. XRD and DSC analyses were used as
complementary tools, showing that the drug in the fibers remains amorphous over
the time period. FTIR results indicated that for the IND formulations, IND-PVP
hydrogen bonding occurs, contributing to the stability of the amorphous IND in the
electrospun fibers. These results show that the technique of electrospinning may be
a good method to produce physically stable, amorphous solid solutions.
With this work, we have also shown that solid state NMR allows us to verify that
an amorphous mixture remains a solid solution throughout a stability study. Tech-
niques that measure the crystallinity, such as XRD and DSC, do not show when phase
separation occurs, which is a likely precursor to crystallization. By using SSNMR re-
laxation time analysis, we are able to obtain a more comprehensive understanding of
the physical stability of amorphous solid solutions.
4.4 Conclusions
Due to the rapid solvent evaporation rate, electrospinning a solution of dissolved API
and polymer often results in amorphous API in the fibers. In Chapter 4, we present
a detailed study of electrospun formulations containing amorphous API, in particular
1:1 SPP:PVP, 4:1 SPP:PVP, 1:1 IND:PVP and 2:1 IND:PVP.
We found that, following electrospinning, these formulations are present as a solid
solution down to a 2-10 nm length scale, and remain as such for 6 mo. storage at 40'C.
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During that time, there is also no evidence that crystallization occurs. One reason for
the high stability of the amorphous form is that the PVP acts as an antiplasticizer
and, since it is mixed to a 2-10 nm length scale or smaller with the API, keeps the
API molecules from arranging into clusters and, subsequently, crystals.
An additional reason for the stability of the amorphous form is hydrogen bonding
of the API with PVP. For the IND formulations, we used IR spectral analysis to show
that hydrogen bonding is, indeed, occurring between the carboxylic acid of the IND
and the amide carbonyl of the PVP. This was supported by the Tg of 2:1 IND:PVP;
the measured Tg was significantly different than that predicted by the Gordon-Taylor
equation.
For the SPP formulations, interactions between the SPP and PVP could not be
conclusively proven. In fact, FTIR analysis showed no peak shifts in some regions
that would be expected to hydrogen bond and the measured Tgs of the electrospun
SPP/PVP mixtures correlated well with those predicted by the Gordon-Taylor equa-
tion. This is logical because SPP is a bulky molecule with much steric hindrance to
hydrogen bonding. It may be, then, that SPP and PVP do not interact via hydrogen
bonding and the stability can be explained only by the decrease in mobility due to
the antiplasticizing effect of PVP.
Electrospinning has been shown here to be a method of producing stable amor-
phous formulations and, for the same materials, is superior to hot melt extrusion.
Though it can also produce phase separated solid dispersions in some cases, as with
IBUss and PVP, the rapid evaporation rate from an initial well-mixed solution aids
the formation of a homogeneous solid solution. Hot melt extrusion, which starts
with a phase separated powder blend is unable to provide the same level of mixing.
Application of electrospinning to manufacturing of amorphous API formulations is
promising and, for some API/polymer mixtures, would result in an acceptably stable
final product.
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Chapter 5
Electrospinning Fibers Containing
Crystalline API
5.1 Introduction
For electrospinning to become generally applicable as a manufacturing process, it
must also be able to produce fibers containing crystalline API. A few studies on
electrospinning of API have found that the API is partially crystalline immediately
after electrospinning [37-39]. They test only one API/polymer formulation each and
do not examine the effect of API/polymer properties on crystallinity in depth. In
Section 5.2 of this chapter, we extend these studies to explore the percent crystallinity
of IBU and CBZ with a wide variety of polymers.
Due to the difficulties in obtaining fully crystalline drug for a variety of APIs and
drug loadings, however, we have also developed a new approach to electrospin crys-
talline API. We use free surface electrospinning to spin suspensions of API particles
in a PVP/ethanol solution. To develop an understanding of the spinnability of mi-
croparticles, we first use 1, 3, 5, and 10 pum polystyrene spheres (Section 5.3) as model
particles. We then apply the method to electrospinning API crystals (Section 5.4).
If a solvent is chosen in which the API is insoluble, the API will maintain its crys-
tallinity during the electrospinning process, resulting in electrospun mats containing
crystalline API dispersed within the polymer fibers. For this work, we selected two
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APIs that are insoluble in ethanol, ABZ and FAM, and chose PVP as the polymer
due to its acceptability as a pharmaceutical excipient and the ease of electrospinning.
5.2 Results and Discussion: Fibers Containing Crys-
talline API from Solutions of API and Polymer
Though it has often been demonstrated that amorphous API can be produced in
electrospun fibers [6,7,108,109], few have studied the crystallization of the API during
electrospinning. Three studies have mentioned crystalline API in the electrospun
fibers [37-39], and only one has attempted to explain why crystallization occurs [39].
Since the evaporation rates are high during spinning, crystallization is rare. Yet,
amorphous dispersions are difficult to stabilize and many drugs have sufficiently high
bioavailability in their crystalline form, so developing a method of producing fibers
containing crystalline API is appealing.
In this section, various polymers with two APIs, IBU and CBZ, are electrospun
from fully dissolved solutions. The focus here is on drug and polymer properties,
neglecting for the time being solvent effects, concentration and drug loading. Many
material properties may affect whether the API crystallizes in the fibers during spin-
ning. With respect to the API, these include glass transition temperature, solubility
in solvent, hydrogen bonding capabilities (donor/acceptor) molecular weight, charge,
and ability to form a solvate. With respect to the polymer, the important properties
include hydrogen bonding capabilities (donor/acceptor), glass transition temperature,
solubility in solvent, molecular weight, melting temperature (or whether crystalline
or amorphous at room temperature), and miscibility with the drug.
5.2.1 Selection of Polymers and API
A variety of polymers have been selected based on their hydrogen bonding capabilities,
crystallinity at room temperature, molecular weight, glass transition temperature and
melting temperature. These are summarized in Table 5.1. The API used in this study
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Polymer Tm (-C) [ Tg (-C) [Hydrogen Bonding [ -State at 25*C Molecular Weight (Da)
Poly(l-lactic acid) (PLLA) 173-178 50-80 Acceptor Slightly Crystalline 103,000
Poly(methyl methacrylate) (PMMA) n/a 85-165 Acceptor Amorphous 300,000
Nylon 3,6 (NY) 190-350 45 Acceptor Amorphous
Poly(acrylic acid) (PAA) n/a 79-100 Donor/Acceptor Amorphous 450,000
Poly(vinyl chloride) (PVC) 100-260 80 Neither Slightly Crystalline 62,000
Polycaprolactone (PCL) 60 -60 Acceptor Crystalline 70-90,000
Polystyrene (PS) n/a 100 Neither Amorphous 280,000
Poly(ethylene oxide) (PEO) 65 -20 Acceptor Crystalline 1,000,000
Poly(vinyl pyrrolidone) (PVP) n/a 190 Acceptor Amorphous 1,300,000
Table 5.1: Melting temperature (Tm), glass transition temperature (Tg), hydrogen bonding behavior, state at room temperature
(25'C) and molecular weight of polymers used in electrospinning experiments.
.0
API I Tm (C) I Tg (*C) I Hydrogen Bonding I Molecular Weight (Da)
CBZ 190 53 Donor/acceptor 236
IBU 75 -45 Acceptor 206
Table 5.2: Melting temperature (Tm), glass transition temperature (Tg), hydrogen
bonding behavior, and molecular weight of CBZ and IBU
are IBU and CBZ, and their properties are listed in Table 5.2.
Though we aimed to electrospin 1:1 API:polymer in all cases, due to solubility
issues, we were often not able to obtain such a high API loading. The exact solutions
electrospun for these studies and the electrospinning parameters may be found in
Table 3.1.
5.2.2 Morphology of Electrospun Fibers Containing Crys-
talline API
The morphology of all formulations electrospun were analyzed using SEM. For most
formulations, the resulting fibers were similar to those containing amorphous API
(Figure 4-1): smooth, relatively uniform diameter, and lacking protrusions from the
fiber. For a few cases, however, the morphology was distinctly different, and these
are shown in Figure 5-1.
For the 1:2 IBU:PEO fibers, the mat was stretched upon mounting on the SEM
stage, providing the pulled-apart look along the fibers. What is obvious from Figure
5-1-A is that the fibers contain rough, stiff regions where crystalline material exists.
CBZ tends to crystallize in a needle shape, and Figure 5-1-B of 1:2 CBZ:PEO
clearly shows small, needle-like protrusions along the length of the fiber, indicating
that there is very clear phase separation between CBZ and PEO and the CBZ crystals
have grown through the polymer.
Two other formulations that display interesting morphology are 1:2 IBU:PCL and
1:2 CBZ:PCL (Figure 5-1-C and 5-1-D, respectively). The first observation of note
from these images is that the fibers are very thick compared to other fibers electrospun
in this work. This is likely due to a combination of the low dielectric constant and
the low boiling point of the solvent, chloroform [110,111]. The dielectric constant is
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Figure 5-1: SEM images of electrospun A. 1:2 IBU:PEO, B. 1:2 CBZ:PEO, C. 1:2
IBU:PCL, D. 1:2 CBZ:PCL, and E. 1:1 IBU:PLLA
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a measure of how well a material can polarize, and a solvent with a low dielectric
constant will have a lower charge density during spinning and thus experience weaker
elongation forces [111]. Due to the low boiling point, evaporation is more rapid,
leaving less time for the weak elongation forces to act and resulting in thicker fibers.
Often, to improve the dielectric constant of the spinning solution, a co-solvent is
used [110]. That was not done here, however, so as not to add additional solvent
effects.
For the IBU/PCL fibers, distinct plate-shaped crystals are visible on the surface of
the fibers. These are likely IBU crystals, as it tends to adopt a plate-like morphology.
The CBZ/PCL fibers looked very similar to the CBZ/PEO fibers, with needle-like
protrusions along the length of the fiber. Both of these images suggest that the API
is significantly phase separated from the polymer and crystallizes either through the
surface of the fiber or solely on the surface of the fiber.
Finally, we were unable to obtain uniform fibers for 1:1 IBU:PLLA, and the best
morphology electrospun can be found in Figure 5-1-E. In general, the electrospun mat
was comprised of large portions of IBU/PLLA containing significant IBU crystals and
small fibers with no visible crystals.
5.2.3 Crystallinity of Formulations Electrospun from an API/Polymer
Solution
Both XRD and DSC were used to evaluate the crystallinity of -IBU and CBZ in
electrospun fibers. XRD was used primarily to confirm the conclusions drawn from
DSC scans, while the DSC data was used to quantitatively determine the percent
crystallinity of the API in the fibers. The percent crystallinity can be estimated by
integrating the area under the melting endotherm for the pure crystalline material
(Ahmelt,API), the melting endotherm for the unknown sample (Ahmet,samp), and any
recrystallization exotherm (Ahrecryst) and using the following equation [86]:
%cryst = Ahmelt,samp - Ahrecryst (5.1)
Ahmelt,API
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Formulation IBU % crystallinity CBZ % crystallinity
1:1 API:PLLA 30, SC 0, AM
1:2 API:PMMA 10, SC 15, SC
1:2 API:NY 0, AM 0, AM
1:2 API:PAA 20, SC 0, AM
1:2 API:PVC 40, SC 40, SC
1:2 API:PCL XRD cryst., HC 70, HC
1:2 API:PS 10, SC 20, SC
1:2 IBU:PEO, 1:1 CBZ:PEO XRD cryst., HC 65, HC
1:2 API:PVP 0, AM 0, AM
Table 5.3: Percent crystallinity of the IBU and CBZ in electrospun fibers prepared
from many polymers. AM=amorphous, SC=slightly crystalline, and HC=highly crys-
talline
This calculation method is only a rough estimate, for it relies on the assumption
that the heat necessary to melt 1 g of crystalline API is equal to the heat necessary
to crystallize 1 g of amorphous API [86], which may not always be the case. In
addition, the sensitivity of the DSC is only 5-10 wt% (see Section 3.5), and since the
API is only approximately 33 wt% of the entire sample, accuracy will suffer at lower
crystallinities.
The measured percent crystallinity for each formulation tested is listed in Table
5.3. Because of the high error associated with using this method to calculate percent
crystallinity for low amounts of crystalline material, we sort the results into three
categories to draw conclusions; amorphous API (AM), less than 50% crystalline API
(slightly crystalline, SC), and greater than 50% crystalline API (highly crystalline,
HC).
For most formulations, we were able to calculate a percent crystallinity from the
DSC data. For 1:2 IBU:PEO and 1:2 IBU:PCL, however, the melting peaks of IBU
and the polymer were too close to separate for analysis. For these formulations,
we rely on XRD powder patterns to conclude that the API in the fibers is highly
crystalline (Figures 5-2 and 5-3).
Only 4 formulations displayed high crystallinity immediately following electrospin-
ning, and all 4 were API with crystalline polymer (PCL or PEO). The two slightly
crystalline polymers, PVC and PLLA, had varying results when spun with API; for
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Figure 5-2: XRD powder patterns for crystalline IBU, crystalline PCL, and 1:2
IBU:PCL
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Figure 5-3:
IBU:PEO
XRD powder patterns for crystalline IBU, crystalline PEO, and 1:2
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PVC both API were slightly crystalline and for PLLA the IBU was slightly crystalline,
but CBZ was amorphous. For the remainder of the API/polymer combinations, there
is no clear pattern with any of the polymer or API properties.
It is clear from these results that crystallization of an API during electrospinning
is dependent on more factors than merely the API and polymer properties. For
one, the solvent effects cannot be neglected, as solvent properties, such as dielectric
constant and boiling point, have a large effect on the behavior of the fiber during
electrospinning. In addition, interactions between the solvent and polymer as well
as solvent and API will affect the phase separation during spinning and thus the
likelihood of crystallization occurring.
In addition, recent studies on the crystallization of a polymer during electrospin-
ning have shown that concentration and viscosity play a role in crystallization of the
polymer. The morphology of polymer crystals (whether the chain layering is parallel
to the fiber length or perpendicular to it) depends on how quickly the fiber dries and
the mobility of the chains during drying [112]. These properties were not controlled
for these studies, as the different API/polymer solutions were only spinnable in a
small window of concentrations near that chosen for the experiments.
A final issue encountered in this work is that it is unknown whether crystallization
takes place while the jet is electrospinning or after collection, but before XRD and
DSC experiments can be performed. Though the samples were all analyzed as soon
as possible after electrospinning was completed, the time required to spin enough
material for analysis was on the order of hours. In some cases, this could be sufficient
for an initially amorphous API to crystallize. Better analysis techniques are required
in order to truly understand when crystallization is occurring.
5.2.4 Summary
For the many API/polymer combinations studied, only 4 displayed highly crystalline
API in the fibers: 1:2 IBU:PCL, 1:2 CBZ:PCL, 1:2 IBU:PEO, and 1:1 CBZ:PEO.
These also correlated with the only polymers that themselves crystallized readily,
indicating that electrospinning with a polymer that tends to crystallize during elec-
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trospinning can lead to crystallization of the API. More work is necessary to un-
derstand the mechanism behind the crystallization and to determine to what extent
crystallization takes place before collection versus after collection but before analysis.
Additionally, it was shown here that crystallization of an API during electrospin-
ning is dependent on more parameters than merely the API and polymer proper-
ties. Besides all of the conditions that play a role in traditional crystallization via
solvent evaporation, including temperature, solvent-API interactions, API concentra-
tion, etc., other parameters will have a strong effect during electrospinning, particu-
larly on the evaporation rate and elongation forces. Further investigation into these
alternate parameters will help determine which conditions are necessary in order to
produce fibers containing crystalline API via electrospinning of a solution of API,
polymer, and solvent.
5.3 Results and Discussion: Spinnability of Parti-
cles using Polystyrene Beads as Model API
One attractive attribute of electrospinning is that other materials can be added to
the polymer/solvent solution and incorporated into the electrospun fibers in order to
make composite fibers. In this section we investigate the spinnability of 1-10 pm PS
beads suspended in an ethanol/PVP solution in order to better understand the use
of free surface electrospinning for suspensions of large particles. With the knowledge
gleaned from this work, the technique can be applied to producing fibers containing
large API particles for application to pharmaceutical manufacturing.
5.3.1 Theory of the Spinnability of Microparticles
For single needle electrospinning of both the 1.3 MDa and 55 kDa PVP solutions in
ethanol, particles should be spinnable at all sizes up to the diameter of the nozzle at
sufficiently low loadings, but for the free surface approach, the particles must remain
suspended in the solution bath, be entrained on the wire along with the fluid and must
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Figure 5-4: A. Fluid entrainment on the wire in the presence of an electric field. The
large circle represents the wire viewed end-on, the small circles are the microparticles
and thin line is the fluid/air interface. The middle image illustrates entrainment of
the fluid with a trailing film. The rightmost image illustrates droplet formation after
breakup of the trailing film; the droplet is drawn asymmetrically about the wire to
represent the influence of the electric field. B. Jetting of the fluid. The small circles
are the microparticles, the thick line is the wire viewed perpendicular to its axis, and
the thin line is the fluid/air interface. The left image represents the droplet profile
prior to jetting, while the right image shows the profile during jetting. The beads are
not drawn to scale.
also remain with the fluid during jetting. The latter two processes are illustrated in
Figure 5-4.
In the entrainment process, the wire electrode experiences several forces (capillary,
inertial, viscous, and gravitational forces) as it travels vertically through the air/liquid
interface of the bath. As the wire approaches the interface, the interface deforms and
coats the upper hemisphere of the wire. Once the wire has passed through the original
position of the interface, liquid begins to drain from the wire, causing a trailing film
to form. At a distance several times larger than the diameter of the wire, the trailing
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film ruptures, leaving liquid entrained on the wire. It is important to note that this
configuration is distinct from previous studies of coating and liquid entrainment on
a cylinder where the cylinder axis is oriented parallel to the interface normal as it is
drawn through the interface. The latter configuration has been.described by Landau
and Levich [113], and Derjaguin [114] and more recently for a fiber by Qu r6 [115].
The configuration employed here is similar to studies where spherical particles are
drawn through an interface by mechanical forces [116,117] or buoyancy forces [118] and
entrain liquid through the draining and rupture of a trailing filament. Computational
studies have shown that the liquid entrainment on a sphere at low Reynolds number
(Re) is highly dependent on the capillary number (Ca), a measure of the viscous
force relative to the surface force, of the system [119-121]. All of the previous studies
describe the entrainment of a liquid on a spherical surface, whereas here we consider
entrainment on a cylindrical surface. To the best of our knowledge, analysis of a
cylinder traveling horizontally through a deformable interface has not been described
prior to a recent study on free surface electrospinning [17], where it was found that
the amount of liquid entrained on the wire could be described by the relation:
- = aCab (5.2)
Tw
where z is the thickness of the uniform liquid film entrained on a wire of radius rw,
and a=0.78±0.03 and b=0.21±0.01 for solutions of PVP in ethanol.
Here we consider whether the polystyrene beads are entrained with the fluid or
remain in the solution bath. In this analysis, we use only the wire electrode type of
free surface electrospinning and assume the particles are perfect spheres of density
equal to that of polystyrene, 1.05 g/cm3 . Due to the low Re of the fluid during
entrainment, it is possible to assume that the beads behave as a dilute suspension of
spheres in a large fluid bath, and the flow can be approximated by Stokes's flow, given
that the bead diameter is much less than the wire diameter. In this work, the wire
diameter is 200 pm, and the largest bead diameters are 10 pm, so the assumption is
reasonable. The main forces acting on the bead are the force due to gravity and the
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Fluid Density Viscosity Surface tension
(g/cm 3) (Pa.s) (mN/m)
1.3 MDa PVP in 0.82 0.137 23
ethanol (8.6 wt%)
55 kDa PVP in 0.85 0.028 23
ethanol (20 wt%)
1.3 MDa PVP (8.6 wt%), 10 pm n/a 0.154 n/a
PS beads (4.3 wt%) in ethanol
55 kDa PVP (20 wt%), 10 pm n/a 0.035 n/a
beads (10 wt%) in ethanol
Table 5.4: Physical properties of the PVP solutions, 8.6 wt% 1.3 MDa PVP with 4.3
wt% 10 pm PS bead in ethanol and 20 wt% 55 kDa PVP with 10 wt% 10 pm PS
beads in ethanol
drag force on the bead due to the liquid. We ignore any electrical forces that may
arise due to accumulation of charge on the PS microparticle itself.
The force due to gravity, taking into account buoyancy, can be determined by:
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Fg = (Ppart - Pf luid) 4rr3g (5.3)
where Ppart is the particle density, Pfluid is the fluid density, r, is the radius of the
particle and g is the gravitational acceleration. The drag force can be calculated by
Stoke's law:
Fdrag = 6 rlrpvrel (5.4)
where T1 is the viscosity of the fluid and Vrel is the relative velocity between the fluid
(Vfluid) and particle (vpart):
Vrel = Vfluid - Vpart (5.5)
In order to determine whether the particles will be entrained on the wire or jet
with the fluid during electrospinning, we calculate Vpart and determine whether it is
positive (travels with the fluid) or negative (left behind). The physical properties of
the polymer solutions used for calculations are listed in Table 5.4.
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We deal first with the settling of the beads in the fluid bath, where Vfluid is equal
to zero. In this case, the settling velocity of the PS beads in 1.3 MDa PVP and 55
kDa PVP, determined by equating Fg and Fdrag and solving for vpart, is very small.
For the largest bead size used in this study, 10 pm, the settling velocity is calculated
to be -3.5 x 10-5 cm/s and -1.5 x 10-5 cm/s for the 1.3 MDa and 55 kDa solutions,
respectively. This is very slow, and means that it would take more than 6 hours for a
particle to travel the depth of the solution bath, 0.8 cm. Since our experiments run
for 30 min, this is not a large concern for this work. For larger particles, the settling
becomes a greater issue, as 100 pm particles are expected to settle out in less than 4
min.
Next we examine the entrainment process. The velocity of the fluid away from
the fluid bath during entrainment can be approximated by the velocity of the wire.
This can be calculated by:
Vf luid= 2rsgrQ (5.6)
where r, is the radius of the spindle and Q is the rotation rate. Equating Fg and Fdrag
(Equations 5.3 and 5.4) and using Equations 5.5 and 5.6 for the relative velocity, the
velocity of the particle can be caculated as a function of the particle diameter, allowing
us to determine whether the particle will remain entrained on the wire.
The predicted velocity of the particle during entrainment was calculated using the
parameters from the experiments. The diameter of the wire was 200 pm, the radius
of the spindle was 3.2 cm, and the rotation rate was 8.8 rpm. The calculated particle
velocity for the 55 kDa PVP and 1.3 MDa PVP solutions was 2.92 cm/s and did not
change appreciably as a function of particle diameter for particle diameters up to 100
Am. This indicates that for particle diameters up to one half the wire diameter, the
velocity is positive and the particles will remain within the fluid during entrainment.
For the inclusion of the beads during jetting, determining the precise velocity of
the fluid is non-trivial. Many researchers have developed methods to analyze the
flow of an electrospinning jet, but they involve complex numerical simulations, which
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are outside the scope of this paper. In lieu of calculating the precise velocity, many
authors estimate the velocity based on the volumetric flow rate (Q):
Vfluid = QA (5.7)
where A is the area of the jet, determined from the radius of the jet immediately past
the Taylor cone. In our case this is approximately 10 pum, based on image analysis. For
needle elctrospinning with a metering pump, Q is a known input parameter, but for
free-surface electrospinning Q is unknown. In order to estimate it, we use the lifetime
of a jet and the volume of the drop, assuming that the flow rate is approximately the
volume of the drop (Vdrop) divided by its lifetime (tjet).
Q = Vdrop (5.8)
tjet
The lifetime of the jet was determined to be 1.28 s for a 30 wt% solution of 55
kDa PVP in ethanol electrospun at an applied voltage of 30 kV [17]. To determine
the volume of the drop, Vdop, we use the correlation reported previously [17]:
27r2 r , [(1 + 0.78Cao 21) 3 - 0.78Ca0 2 -- 1 (
0.0028VA + 0.5
where Ca = ""f"luid, VA is the applied voltage in kV, rw is the radius of the wire in km,
Vfluid is the velocity of the fluid during entrainment and 7 is the surface tension of the
fluid. The solutions employed in Ref [17] are similar to the 20 wt% 55 kDa and 8.6
wt% 1.3 MDa PVP solutions used in this work and were also spun at approximately
30 kV, so the values and correlations reported there are taken as a first approximation
here as well.
Equating F and Fdrag, Equations 5.3-5.5 and 5.7-5.9 may be solved to yield the
velocity as a function of particle diameter, allowing us to determine whether the
particles remain in the fluid during entrainment and jetting. This results in a velocity
of approximately 10.6 cm/s for particle diameters up to 100 pim for both polymer
solutions, indicating again that PS particles up to a 100 pim diameter should be
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Figure 5-5: Measured mass loading of polystyrene beads in electrospun fibers as a
function of the nominal mass loading for both free surface (filled diamonds) and
single needle (open squares) electrospinning. The parity line assuming complete and
uniform entrainment is shown by the solid line, and the dotted lines represent ± 10
wt%.
spinnable with the PVP/ethanol solutions.
5.3.2 Loading of Polystyrene Beads in Electrospun Fibers
One way of assessing whether the particles were actually entrained in the fluid on the
wire or remained with the fluid during jetting is to examine the final loading of PS
in the fiber mat. To do this, we measured the weight percent of the PS in the fiber
mats for both the free surface and single needle electrospinning. Approximately 30
mg of the solid fibers were washed with ethanol, dissolving the PVP and washing it
through a filter (1 pm pore size for the 3, 5, 10 pm PS beads and 0.45 lm pore size for
the 1 pm bead size). The final mass of the filter was determined after drying under
vacuum, and the mass of the PS beads was calculated by subtracting the initial mass
from the final mass. The measured mass loading is plotted in Figure 5-5 against the
nominal mass loading for all solutions electrospun in this study.
The method for determining loading results in an error of approximately t 10
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wt%, due to the low mass being analyzed and the uncertainty of the balance, so we
have included the +10 wt% and -10 wt% boundaries (dotted lines) in Figure 5-5. The
limited accuracy of the measurement is confirmed by the single needle electrospinning
results, where entrainment is not an issue and all points should fall on the parity line,
according to conservation of mass. In order to evaluate how well particles are spun in
free surface electrospinning, then, we can compare it to single needle electrospinning.
Most points for both cases fall within the 10 wt% error boundaries. There are two
points that fall outside of the boundaries for the single needle electrospinning and
three points that fall outside for free surface, an insignificant difference. Thus, we
conclude that there are no large deviations of the loading from the expected loading,
and the solutions are spinnable. This is also consistent with observations from SEM.
5.3.3 Fiber Morphology and Diameter
All samples were examined by SEM to determine their morphology. In Figures 5-
6 and 5-7, sample SEM images are shown from free surface electrospun fiber mats.
Figure 5-6 shows images of the 1.3 MDa PVP, 1:5 PS:PVP mass loading mats for all
four different PS bead sizes. It can be seen from these images that the fibers have a
mostly smooth morphology and their diameters are smaller than the size of the beads.
Figure 5-7 shows images for the 1.3 MDa PVP, 3 pm beads for the three different
mass loadings used in the experiments: 1:10, 1:5, and 1:2 PS:PVP. It is obvious from
these images that the fiber morphologies, i.e. smooth and uniform between beads,
with fiber diameters smaller than the bead size, are very similar from one sample to
the next, independent of the mass loading of the PS beads. From this we conclude
that the loading has no effect on fiber morphology up to a 1:2 PS:PVP ratio.
An average fiber diameter calculated from at least 80 measurements was deter-
mined for each of the samples. From the results in Table 5.5, one can see that the
fiber diameter is independent of the PS bead diameter within each similar group
(same PVP base solution and same bead loading). For all cases, the average fiber
diameters fall within the widths of the fiber diameter distributions of one another.
To examine the effect of bead loading, we compared the fiber diameters to the fiber
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Figure 5-6: SEM images of electrospun A. 1 pm beads, 1:5 loading, 1.3 MDa PVP,
average fiber diameter 1.07 ± 0.17 pm; B. 3 pm beads, 1:5 loading, 1.3 MDa PVP,
average fiber diameter 1.17 ± 0.23 pm ; C. 5 pm beads, 1:5 loading, 1.3 MDa PVP,
average fiber diameter 0.97 + 0.32 pm; and D. 10 pm beads, 1:5 loading, 1.3 MDa
PVP, average fiber diameter 1.05 t 0.32 pm
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Figure 5-7: SEM images of electrospun A. 1:10 loading, 3 pm beads, 1.3 MDa PVP,
average fiber diameter 1.33 ± 0.25 pm; B. 1:5 loading, 3 pm beads, 1.3 MDa PVP,
average fiber diameter 1.23 i 0.18 pm; and C. 1:2 loading, 3 jim beads, 1.3 MDa
PVP, average fiber diameter 0.97 t 0.22 pm
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Bead Diameter (pm) PS:PVP loading PVP Mw Diameter (pm)
+/- width of distribution
1 1:10 1.3 MDa 1.11 t 0.22
3 1:10 1.3 MDa 1.33 ± 0.25
5 1:10 1.3 MDa 1.17 t 0.30
10 1:10 1.3 MDa 0.94 ± 0.21
1 1:5 1.3 MDa 1.13 t 0.23
3 1:5 1.3 MDa 1.19 t 0.22
5 1:5 1.3 MDa 0.88 t 0.22
10 1:5 1.3 MDa 0.98 t 0.30
1 1:2 1.3 MDa n/a*
3 1:2 1.3 MDa 0.96 ± 0.18
5 1:2 1.3 MDa 0.88 i 0.15
10 1:2 1.3 MDa 1.11 t 0.34
1 1:10 55 KDa 0.66 i 0.08
3 1:10 55 KDa 0.48 i 0.16
5 1:10 55 KDa 0.56 ± 0.10
10 1:5 55 KDa 0.47 t 0.11
1 1:5 55 KDa 0.66 t 0.15
3 1:5 55 KDa 0.84 t 0.27
5 1:5 55 KDa 0.50 ± 0.12
10 1:5 55 KDa 0.60 t 0.22
1 1:2 55 KDa 0.56 i 0.10
3 1:2 55 KDa 0.56 + 0.12
5 1:2 55 KDa 0.53 t 0.11
10 1:2 55 KDa 0.54 t 0.14
None None 1.3 MDa 1.19 t 0.44
None None 55 KDa 0.72 t 0.23
electrospun, *Could not
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Table 5.5: Average diameter of the fibers for each solution
be measured due to aggregation, see Figure 5-10-B.
diameters for PVP fibers containing no PS beads. The average fiber diameter for 1.3
MDa PVP fibers containing no beads spun under the same conditions is close to that
for all bead-containing fibers electrospun from the 1.3 MDa PVP base solution. In
addition, all values for the 55 kDa PVP containing beads fall near the average for
55 kDa fibers containing no beads. These results indicate that the fiber diameter is
independent of the bead size as well as bead loading for the materials studied. The
fiber diameter can thus be adjusted independently of the diameter of the bead and
bead loading, up to a 10 pm bead diameter and a 1:2 bead to polymer loading, by
adjusting the base solution properties, for example by changing the concentration or
molecular weight of the polymer. Further work is necessary to determine whether the
relationship between fiber diameter and the various solution properties follow identical
trends as for solutions without particles, as this study examined only a small subset
of solution properties.
5.3.4 Discussion
All formulations chosen for this work were "electrospinnable". This is consistent with
the predictions based on particle settling, fluid entrainment and jetting. In fact, for
a scenario where the polymer fluid was the 8.6 wt% 1.3 MDa PVP used in this study
and the particle density was as high as lead (approximately 12 g/cm3 ), the beads
would still be expected to be entrained in the fluid up to a diameter of 100 pm, as
can be seen in Figure 5-8.
For a particle of such high density, however, the settling velocity becomes very
high. For the case of 8.6 wt% 1.3 MDa PVP and a lead particle, the settling velocity
for a 5 pm particle is -2 x 10-4 cm/s, for a 30 pam diameter particle is -0.007 cm/s and
for a 100 pm particle is -0.08 cm/s, corresponding to complete settling times of 4000
s, 110 s, and 10 s, respectively. To test whether lead particles would be entrained in
the fluid and jet, we scattered lead particles of diameter less than 44 pm onto the
top of the fluid bath and immediately began spindle rotation and application of the
electric field. We allowed the spinning to progress for approximately 30 s and then
analyzed the as-received powder and fibers via SEM (Figure 5-9).
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Figure 5-8: Predicted velocity of particles during fluid entrainment as a function of
particle diameter for a solution of 8.6 wt% 1.3 MDa PVP and a particle with the
density of lead
Figure 5-9: SEM images
PVP/lead fibers (right)
of lead particles as received (left) and electrospun 1.3 MDa
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Figure 5-10: SEM images of A. aggregation of particles for single needle electrospin-
ning of 1:2 loading, 1.3 MDa PVP and 10 pm beads and B. aggregation of particles
for free surface electrospinning of 1:2 loading, 1.3 MDa PVP and 1 pm beads
It is clear from Figure 5-9 that lead particles of greater than 10 pm are spinnable
with 8.6 wt% 1.3 MDa PVP if the particles can be made to remain suspended in the
fluid bath.
One additional challenge identified in these studies is aggregation of the particles.
For some of the single needle formulations, the spinning was so slow that aggregation
of particles occurred in the syringe prior to spinning, resulting in aggregates present
in the fibers rather than single, separated beads. This is illustrated in Figure 5-
10-A for 10 ptm PS beads in a 1:2 PS:PVP mass loading prepared by single needle
electrospinning.
Aggregation may also be an issue in free surface electrospinning, as can be seen in
Figures 5-6-B, 5-7-C and 5-10-B. Though not performed in this study, this challenge
could be addressed through use of agitation in the solution bath during spinning or
incorporation of a surfactant in the electrospinning solution.
In addition, high bead loadings could also produce challenges, both with respect
to aggregation, as seen in Figure 5-10-B, as well as with respect to fluid entrainment,
as all of the entrainment predictions in this work applied the assumption of a dilute
solution. Further work is necessary to understand the behavior of particles during
electrospinning at high particle loadings.
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5.3.5 Summary
Electrospinning has been a useful tool for producing nanofibers for a number of years,
and here we present a case for its application to create fibers with more complex
geometries by electrospinning microparticles up to a diameter of 10 pm. Various
bead diameters and polymer molecular weights were shown to be spinnable up to a
1:2 PS:PVP mass loading. The final fiber diameters were independent of the bead size
and bead loading, but were dependent on the solution properties, such as viscosity
and conductivity, and similar to fibers spun without any beads at all. This indicates
that a wide variety of particles can be electrospun for many applications and the final
bead and fiber dimensions can be controlled. In addition, this is manageable using
the high-throughput free surface electrospinning apparatus, meaning it has a greater
potential for application to an industrial process.
5.4 Results and Discussion: Fibers Containing Crys-
talline API from Suspensions
Due to the difficulties in obtaining fully crystalline drug for a variety of APIs and drug
loadings (Section 5.2), we developed a new approach to electrospin fibers containing
crystalline API. It has previously been demonstrated that nano- and microparticles
can be electrospun starting from a dispersion of the particles in a polymer solution.
The particles can be very small, 20 nm or less, as with magnetite [40], TiO2 [41,42]
and carbon black [45] or larger, 1-10 ptm, as with bacteria and viruses [50], clays
[51,52] and polystyrene beads [122] (Section 5.3). Though most work has been done
electrospinning particles using a single needle apparatus, we recently demonstrated
that polystyrene beads of 1-10 pm diameter can be electrospun from PVP solutions
using free surface electrospinning (Section 5.3).
In this section, we use free surface electrospinning to spin suspensions of API crys-
tals in a PVP/ethanol solution. If a solvent is chosen in which the API is insoluble,
the API will maintain its crystallinity during the electrospinning process, resulting in
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electrospun mats containing crystalline API dispersed within the polymer fibers. For
this work, we selected two poorly water soluble APIs that are insoluble in ethanol,
albendazole (ABZ) and famotidine (FAM), and chose PVP as the polymer due to its
acceptance as a pharmaceutical excipient and the ease of electrospinning. We demon-
strate that the API crystals are entrained within the fibers, retain their crystalline
morphology during spinning, and exhibit improved dissolution rates when compared
to compressed powder tablets.
5.4.1 Particle Size Analysis
The particle size distributions of the API crystals suspended in the PVP/ethanol
solution were measured prior to sonication, after sonication and after standing for
1 hour, approximately the length of time to electrospin the mat for analysis. The
distributions for the ABZ and FAM suspensions are shown in Figures 5-11 and 5-12.
For ABZ, the sonication greatly decreases the crystal size. This is likely due
to dispersal of aggregates rather than crystal breakage, as SEM images of the ABZ
crystals show agglomerates of smaller crystals (Figure 5-13-A). The FAM particle
size distribution does not show a strong change following sonication. This is likely
because the FAM crystals are less agglomerated in the powder, as can be seen in
Figure 5-13-B. Following 1 hour of standing, both suspensions retain their particle
size distribution, indicating that the suspensions electrospun will retain their particle
size distribution throughout the entire 1 hour electrospinning process.
5.4.2 Characterization of Fibers Containing Crystalline API
The morphologies of the electrospun fibers were examined by SEM and the images
are shown in Figure 5-14.
In both cases, the API crystals present in the electrospun fibers are easily visible.
For the ABZ dispersed in the PVP mat, the crystals are present in the fibers as small
agglomerates as well as dispersed crystals, which can be seen by careful examination
of the roughness of the fibers. FAM dispersed within PVP, on the other hand, shows
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Figure 5-11: Particle size distributions by volume of 4.3 wt% ABZ crystals suspended
in 8.6 wt% PVP in ethanol A. before sonication, B. after sonication, and C. after 1
hour
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Figure 5-12: Particle size distributions by volume of 4.3 wt% FAM crystals suspended
in 8.6 wt% PVP in ethanol A. before sonication, B. after sonication, and C. after 1
hour
117
Figure 5-13: SEM images of A. ABZ crystals as received and B. FAM crystals as
received
Figure 5-14: SEM images of A. 1:2 ABZ:PVP electrospun, B. 1:2 FAM:PVP elec-
trospun, C. 1:2 ABZ:PVP electrospun at higher magnification, D. 1:2 FAM:PVP
electrospun at higher magnification
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little agglomeration and good dispersion of the API in the fibers. It is interesting to
note that the FAM crystals are always distributed with their longest side parallel to
the fiber. This can be attributed to the high shear forces during jetting [48].
XRD and DSC were both used to examine the crystallinity of the API within the
electrospun fibers. For 1:2 ABZ:PVP, the melting endotherm is broad with an onset
melting point of 165'C, indicating that the ABZ is crystalline in the fibers (Figure
5-15). The onset melting point is depressed from that of the crystalline ABZ as
received, 190*C. The onset melting of ABZ is consistent with that of Form I of ABZ
shown in the literature [123].
The first onset melting point for crystalline FAM as received is 160*C, and based
on the DSC results (Figure 5-16), there is a broad melting endotherm for the 1:2
FAM:PVP with an onset at 150C. This melting point corresponds to polymorph
B [124]. There is a second melting endotherm for the crystalline material as received
with on onset at 167*C corresponding to polymorph A [124]. This melting endotherm
is also present for the 1:2 FAM:PVP electrospun material with an onset at 167"C.
This indicates that both the crystalline material as received and the FAM in the final
electrospun fibers are mixtures of polymorphs A and B.
The DSC scans also provide evidence that the APIs are well-dispersed within the
fibers. The depression of the melting points of the APIs and the broadening of the
melting endotherms indicate that the APIs are well-dispersed and form a partially
miscible blend with the polymer as the APIs melt during the temperature ramp of
the DSC experiment [125].
XRD powder patterns were used to determine which crystalline polymorph is
present following electrospinning. Figures 5-17 and 5-18 compare the experimental
powder patterns to the calculated powder patterns from the Cambridge Structural
Database.
For ABZ, both the crystalline material as received and the 1:2 ABZ:PVP electro-
spun powder patterns show the same peaks as the calculated powder pattern for form
I from the Cambridge Structural Database (Figure 5-17), reference code BOGFUZ.
The powder patterns for the crystalline ABZ as-received and 1:2 ABZ:PVP electro-
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Figure 5-16: DSC scan of crystalline FAM powder and 1:2 FAM:PVP electrospun
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Figure 5-17: XRD powder pattern of crystalline ABZ powder, 1:2 ABZ:PVP electro-
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Figure 5-18: XRD powder pattern of crystalline FAM powder, 1:2 FAM:PVP electro-
spun and calculated powder patterns of polymorphs A and B
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spun are also consistent with the experimental powder patterns of the commercial
form (form I) as presented by Pranzo et al [123]. The polymorph of the ABZ was not
affected by the electrospinning process.
The powder patterns for the crystalline FAM as received and 1:2 FAM:PVP elec-
trospun are mixtures of polymorphs A and B (Figure 5-18), as can be seen by compar-
ing them to the calculated powder patterns from the Cambridge Structural Database
(reference codes FOGVIG06 and FOGVIG07 for polymorphs A and B, respectively).
Though many peaks are overlapping, the presence of peaks at both 10.7 degrees 2-
theta and 11.7 degrees 2-theta confirm the presence of both polymorphs. Differences
in relative peak intensities can be attributed to the difference in sample preparation.
The powder samples were flattened onto the zero background plate in a disordered
manner, while the electrospun mat was laid onto the plate with all the fibers parallel
to the flat plate.
5.4.3 Loading of API in Electrospun Fibers
The weight percent API in the electrospun fibers was determined using UV-vis spec-
trophotometry. The average loading of ABZ in the fibers was 31 wt% and the average
loading of FAM in the fibers was 26 wt %. Compared to the nominal API loading of
33 wt%, both cases showed lower loading than expected.
In order to examine why the loading is lower than expected, we can calculate the
settling velocity, v, as a function of the particle radius using equation
V = (part - Pfluid) 2 (5.10)
where Pfluid is the fluid density, Ppart is the particle density, p is the viscosity, g
is the gravitational acceleration and r, is the particle radius. The fluid density and
viscosity used were the same as 8.6 wt% 1.3 MDa PVP in ethanol used previously
(Section 5.3.1). The particle densities were taken from the Cambridge Structural
Database and were 1.56 g/cm3 and 1.38 g/cm 3 for FAM and ABZ, respectively (refer-
ence codes BOGFUZ, FOGVIG06 and FOGVIG07 for ABZ, FAM polymorph A and
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FAM polymorph B, respectively). This velocity is based on Stoke's law and thus is for
spherical particles. Though our particles are more plate-shaped, we use a spherical
approximation here for simplicity.
From the settling velocity, we can determine the time required for a particle of a
given radius to settle to the bottom of the electrospinning bath. The distance between
the top of the fluid level when full and the lowest point of the wire rotation is 0.8 cm.
Since the particles are dispersed evenly within the fluid at the start of the experiment,
we assume that an average particle must travel 0.4 cm, or half the depth of the bath.
Once the time required to settle is determined for a range of particle diameters,
we determine the smallest particle diameter that we expect to settle out in 1 hour,
the length of our experiment. For ABZ that is 82.5 pm and for FAM that is 70.8 pm.
The particle size distribution based on volume percent is known for these solutions
from the Malvern results discussed previously, and we have determined that 0.1 vol%
ABZ and 4.5 vol% FAM (0.14 wt% ABZ and 7.1 wt% FAM) is expected to settle
out during the experiment time. These values are merely an estimate, due to the
assumptions of spherical particles and the average distance traveled and the time,
but they provide insight into the difference in the final API loading in the fibers for
the two API chosen for this study. For this method to be applied to a large continuous
process, a stirring mechanism in the bath or a surfactant must be used to keep the
particles suspended. In a larger, continuous operation set-up, the suspension will be
continuously pumped into the fluid bath, which itself may be sufficient to remove the
effects of settling out.
5.4.4 Dissolution of Electrospun Formulations Containing Crys-
talline API
Tablets prepared from a powder mixture and electrospun material were subjected to
USP dissolution tests to compare the release behavior of the two preparation methods.
Market formulations of the APIs were not used for comparison because we aim to
examine only the effects of using the electrospinning preparation method compared
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Figure 5-19: Dissolution of 1:2 ABZ:PVP tablets made from compressed powder
(dashed line) and electrospun material (solid line) over time
to a powder-based preparation method. Electroprocessed materials may be further
optimized for better dissolution through the use of additional excipients in the same
manner as is done for a market formulation and then the two may be compared.
All tablets tested had the same mass and were prepared using the same insertion
depth, meaning that the surface area and volume of the tablets is the same for all
tested. The dissolution curves for ABZ are shown in Figure 5-19 and for FAM are
shown in Figure 5-20.
For both ABZ and FAM, the electrospun formulations showed marked improve-
ment in the dissolution rate over the compressed powder tablets. The crystal size,
the extent of dispersion in the polymer and the crystalline morphology are essen-
tial properties of the electrospun API/polymer mixture that will have an effect on
the dissolution of the APIs, and thus on the effectiveness of the final formulation.
Understanding these properties is essential to the application of this process in a
pharmaceutical manufacturing line.
From both the particle size analysis of the spinning suspension and the SEM im-
124
100
90 - - - Powder
i 80 - Electrosp An
70
60
50
S40 L I
30 ..f .. - -r
0
0 20 40 60 80 100
Time (min)
Figure 5-20: Dissolution of 1:2 FAM:PVP tablets made from compressed powder
(dashed line) and electrospun material (solid line) over time
ages we have determined that the crystals range in size from 0.1-100 pLm, with a
volume percent-based mean of approximately 10 pm. For ABZ in particular, son-
ication treatment prior to electrospinning decreased the measured particle size by
breaking up aggregates. The crystals are relatively small, and thus are expected to
enhance the dissolution rate through an increase in the surface area, as predicted by
the Noyes-Whitney equation, Equation 2.1.
In order to take advantage of the small crystal size to enhance the dissolution rate,
the particles must be kept from aggregating. Using electrospinning, this is done by
trapping the particles within the small polymer fibers. The SEM images in Figure
5-14 show that the particles are present and separated in the polymer fibers. This
occurs due to the rapid solvent evaporation following the dispersion using sonication.
Once in the dried solid form, the particles remain dispersed until the polymer begins
to dissolve during dissolution testing.
As predicted by the Noyes-Whitney equation and supported by the evidence of
formation of a well-dispersed solid mixture, the dissolution rate of the API from
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compressed electrospun tablets is significantly higher than from compressed powder
tablets. As the highly soluble polymer in the electrospun fibers dissolves, the API
crystals are released as individual crystals and the exposed surface area is larger
than that for agglomerates of API in the compressed powder tablets, resulting in an
increased dissolution rate.
5.4.5 Summary
Nanofibers containing a well-mixed dispersion of crystalline API and a polymer were
prepared by electrospinning a suspension of crystals in a polymer solution using a
high-throughput free surface electrospinning process. The final loading in the fibers
was 31 wt% and 26 wt% for 1:2 ABZ:PVP and 1:2 FAM:PVP, respectively, and the
APIs retained their crystalline morphology throughout the electrospinning process.
Due to the small particle size and dispersion of the particles in the polymer, the
dissolution rate was enhanced for compressed electrospun tablets when compared to
compressed powder tablets. This study proposes a novel process for preparing solid
dispersions of crystalline API via electrospinning and demonstrates that the APIs are
well-dispersed, retain their polymorphism, and have a high dissolution rate compared
to compressed powder tablets and thus that electrospinning would be a viable option
for a downstream pharmaceutical manufacturing process.
5.5 Conclusions
For electrospinning to be accepted as a viable pharmaceutical manufacturing process,
it must be sufficiently flexible to produce API formulations with many properties,
including both amorphous and crystalline API. In this section, we explore two meth-
ods to electrospin materials containing crystalline API. The first is spinning from a
fully dissolved solution of API and polymer and the second is from suspensions of
crystalline API in a dissolved polymer solution.
Electrospinning fibers containing crystalline API from fully dissolved solutions has
been demonstrated previously [37-39], but here we extend the study to include a wider
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variety of polymers. From this work we found that electrospinning solutions with a
polymer that crystallizes readily can result in highly crystalline API in the polymer
fibers. Besides that particular polymer property, there were no clear correlations
between polymer or API properties and the crystallinity of the API in the final fibers.
This is because many other conditions, including the solvent properties, interactions
between the solvent and polymer or API, polymer concentration, etc., will affect the
crystallization of the API. In addition, further work is necessary to develop a method
to measure the crystallization occurring during spinning, rather than after hours of
collection.
The crystallinity of API in the electrospun fibers following electrospinning of a
solution of API, polymer and solvent was found to depend on many factors and often
result in only partially crystalline materials. To provide an alternative method of
manufacturing fibers containing crystalline API, we explored a method of spinning a
suspension of particles in a dissolved polymer solution. The particles were placed in a
solution of polymer and a solvent in which they were insoluble, sonicated to disperse
them evenly, and the solution was electrospun on a free surface apparatus.
To develop an understanding of the spinnability of particles of the same order
of magnitude as API crystals, we used spherical polystyrene beads of 1, 3, 5, 10
pm diameter. These were found to be spinnable at loadings up to 1:2 PS:PVP for
two different PVP molecular weights, 1.3 MDa and 55 kDa. Even a particle with the
density of lead (12 g/cm3 ) was found to be spinnable using free surface electrospinning,
provided it can remain suspended in the fluid bath for the entire experiment time. The
fiber diameter was found to be independent of PS bead diameter and bead loading,
but dependent on the base polymer solution (8.6 wt% 1.3 MDa PVP or 20 wt% 55
kDa PVP).
With the knowledge of spinnability of particles obtained from the PS bead work,
we applied our study to electrospinning suspensions of API crystals in a polymer
solution. ABZ and FAM, poorly water soluble APIs, were electrospun in a 1:2
API:polymer ratio with a PVP/ethanol solution, and the final fibers contained 31
wt% ABZ and 26 wt% FAM, slightly lower than expected due to particles settling
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out during the experiment time. The resulting crystals were well-dispersed in the
polymer and maintained their crystalline morphology throughout the electrospinning
process. Dissolution studies showed that tablets prepared from electrospun materials
had a higher dissolution rate than those prepared from blended powder, likely due to
the fine dispersion of small crystals in the water-soluble polymer.
A free surface electrospinning process has been shown to be useful for preparing
pharmaceutical formulations containing crystalline API with improved dissolution
properties compared to compressed powder. With further refinement, this could
lead to the application of electrospinning as a unit operation in a pharmaceutical
continuous manufacturing process.
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Chapter 6
Conclusions and Recommendations
Through the results in this thesis, we have demonstrated the utility of electrospin-
ning as a method of preparing drug products that may be applied to a continuous
manufacturing process. Formulations containing amorphous or crystalline API can
be prepared using the same equipment, and selection of the spinning method, by
spinning a solution or suspension, and appropriate polymers will determine whether
crystalline or amorphous API will be present in the fibers.
By studying the amorphous solid mixtures formed by electrospinning in depth, we
were able to come to the following conclusions:
1) Electrospun API/polymer formulations are homogeneous down to a 2-10 nm
length scale for 1:1 SPP:PVP, 4:1 SPP:PVP, 1:1 IND:PVP, and 2:1 IND:PVP, as
demonstrated using solid state NMR relaxation time analysis.
2) Electrospinning may be used to prepare homogeneous solid solutions in situa-
tions where hot melt extrusion results in phase separated mixtures.
3) The electrospun API/polymer formulations in (1) remain homogeneous to a
2-10 nm length scale for 6 months when stored in a desiccator at 40C due to the
antiplasticizing effect of the PVP and, for IND, the PVP-IND hydrogen bonding
interactions.
4) SSNMR relaxation time analysis may be used to detect phase separation in
electrospun mixtures as well as compare methods of forming solid dispersions.
Overall, the studies have demonstrated that electrospinning has great potential
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as a method for forming amorphous solid solutions that may be used as final drug
products. However, additional work would be useful to better understand the stability
of the API/polymer solutions. Though the FTIR studies gave some indication of
the presence or absence of hydrogen bonding, they were not completely conclusive,
particularly for SPP/PVP formulations. Further study with 2D solid state NMR
correlation spectroscopy would greatly improve the understanding of interactions. 2D
NMR can show which carbons are within close proximity to one another and has been
used to elucidate the structure of complicated molecules [126,127]. The disadvantage
of 2D NMR is that the sensitivity must be very high, and thus the sample must be
"C labeled, an expensive process. However, the depth of information that may be
obtained from 2D NMR correlation spectroscopy would add significant understanding
to the chemical environment in the electrospun fibers.
Additional solid state NMR relaxation time stability studies would also be benefi-
cial to aid in understanding the crystallization of an API over time in the solid state.
Both formulations studied in this work were stable over the 6 mo. analysis time.
Choosing materials that are unstable over time, such as ones that cannot hydrogen
bond and have a Tg closer to the storage temperature, may result in phase separation
over time. Solid state NMR relaxation time analysis performed frequently on such a
sample would determine when phase separation occurs, and that could be correlated
with the time crystalline material is first detected in the sample. This would show
whether the API molecules form a significant solid state cluster prior to crystallization
or whether the crystallization occurs prior to the formation of the 2-10 nm clusters.
The work in this thesis pertaining to forming fibers containing crystalline API by
electrospinning resulted in the following conclusions:
1) Electrospinning a fully-dissolved solution of API, polymer, and solvent can
result in crystalline API in the fibers, particularly when a crystalline polymer is used,
but the crystallinity of the API depends on more factors than merely the API and
polymer properties.
2) Microparticles up to a 10 pm diameter are electrospinnable using free surface
electrospinning provided they are able to remain suspended in the fluid bath.
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3) The fiber diameter of fibers containing microparticles up to a 10 pm diameter
and 1:2 particle:polymer loading is independent of the particle diameter and particle
loading.
4) Fibers containing well-dispersed API crystals with improved dissolution prop-
erties over compressed powder can be prepared by free surface electrospinning of API
crystal suspensions.
The method of electrospinning suspensions has great promise for use in a contin-
uous pharmaceutical manufacturing process, as it is simple and easily combined with
upstream processes. Prior to application, however, additional polymer/API systems
must be studied. In particular, additional polymers that would make good carriers
must be identified, as not all APIs are insoluble in ethanol or other solvents in which
PVP is soluble. In addition, for some APIs, the solvent may induce a change in the
polymorph of the API [128]. In considering electrospinning as a downstream stage in
a pharmaceutical manufacturing process, one must carefully consider the effect of the
solvent, polymer and the sonication process on the API crystalline morphology.
Though direct electrospinning of an API/polymer/solvent solution for producing
fibers containing crystalline API may not be as feasible as electrospinning suspensions
of API crystals, extension of the study in this work (Section 5.2) would aid in applying
electrospinning to prepare amorphous formulations, as understanding why an API
crystallizes in the fiber can help one avoid crystallization when desired. In order to
continue the study, however, a better method of determining when crystallization
occurs is necessary. One approach to on-line characterization of crystallinity is in situ
Raman. It has previously been applied in electrospinning to determine the solvent
remaining in the fibers at different points in the electrospinning process [60].
Extending the study of electrospinning fibers containing crystalline API from a
solution must include rigorous control and exploration of polymer concentration, API
concentration, API-solvent interactions (and solubility), polymer-solvent interactions
(and solubility), solvent dielectric constant, and solvent boiling point. Ideally, a
polymer/API system would be used that is soluble in many solvents, and percent
crystallinity in the final product would be measured for various concentrations for
131
each solvent. What is key is that the crystallization not be viewed merely as a
standard evaporation process, but that the variation in the evaporation rate during
the electrospinning process as well as the behavior of the polymer during spinning be
considered.
The free surface electrospinning process may soon be ready for translation to a
pharmaceutical pilot plant, such as that known as the "Red Line" at MIT. However,
further development is necessary to design a method of continuously processing the
non-woven mats of fibers into tablets. The mechanical properties of the electrospun
mats must be understood and used to design additional equipment for this final
downstream process.
Incorporation of electrospinning into a pharmaceutical manufacturing process
should be feasible for many different APIs and desired product forms. This pro-
cess is exciting because it can form homogeneous solid solutions for poorly water
soluble APIs, but also be used to form crystalline formulations for APIs where en-
hanced solubility is not critical. It is easily incorporated after upstream purification
steps and can be operated continuously at high production rates using free-surface
electrospinning. It is a very promising addition to the toolbox of new continuous unit
operations for pharmaceutical processing.
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